-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PGCDGkNh0vLgQ5SUuoqNv1qjUelci82jyG2xzwOtUBEtUnwF9dWouQysTgQbk4Hp MUn+QHsRrxS0YXPTx+9ERQ== 0001193125-09-035647.txt : 20090224 0001193125-09-035647.hdr.sgml : 20090224 20090224080123 ACCESSION NUMBER: 0001193125-09-035647 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20090224 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20090224 DATE AS OF CHANGE: 20090224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 09629490 BUSINESS ADDRESS: STREET 1: 13737 NOEL ROAD CITY: DALLAS STATE: TX ZIP: 75240 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 13737 NOEL ROAD CITY: DALLAS STATE: TX ZIP: 75240 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report: February 24, 2009

(Date of earliest event reported)

 

 

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

 

Nevada   1-7293   95-2557091
(State of Incorporation)   (Commission File Number)  

(IRS Employer

Identification Number)

13737 Noel Road

Dallas, Texas 75240

(Address of principal executive offices, including zip code)

(469) 893-2200

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition.

The information contained herein is being furnished pursuant to Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On February 24, 2009, Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of the Company for the quarter and full year ended December 31, 2008. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits

 

99.1    Press Release issued on February 24, 2009

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TENET HEALTHCARE CORPORATION
By:  

/s/ Biggs C. Porter

  Biggs C. Porter
  Chief Financial Officer

Date: February 24, 2009

 

3


EXHIBIT INDEX

 

99.1    Press Release issued on February 24, 2009

 

4

EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

LOGO

 

       

Headquarters Office

13737 Noel Road, Ste.100

       

Dallas, TX 75240

tel: 469.893.2000

fax: 469.893.8600

www.tenethealth.com

     Contacts:   
             Media:    David Matthews (469) 893-2640
        David.Matthews@tenethealth.com
             Investors:    Thomas Rice (469) 893-2522
        Thomas.Rice@tenethealth.com

Tenet Announces Results for Fourth Quarter

Ended December 31, 2008 and 2009 Outlook

Highlights:

 

   

0.1 percent growth in same-hospital paying admissions

 

   

0.2 percent decline in same-hospital total admissions

 

   

0.9 percent growth in same-hospital paying outpatient visits

 

   

0.3 percent decline in total same-hospital outpatient visits

 

   

2.1 percent growth in same-hospital surgeries

 

   

3.7 percent growth in same-hospital outpatient surgeries

 

   

3.0 percent decline in same-hospital commercial managed care admissions

 

   

0.2 percent decline in same-hospital commercial managed care outpatient visits

 

   

6.6 percent increase in same-hospital commercial managed care revenues

 

   

$199 million in total adjusted EBITDA, an increase of 27.6 percent

 

   

$201 million in same-hospital adjusted EBITDA, an increase of 27.2 percent

 

   

$29 million use of cash in adjusted free cash flow from continuing operations

 

   

$130 million in capital expenditures in continuing operations

 

   

$507 million in cash and equivalents at Dec. 31, 2008, down $5 million from Sept. 30, 2008

 

   

Bad debt ratio of 7.6 percent of net revenues, an increase of 110 basis points from Q4’07

DALLAS – February 24, 2009 – Tenet Healthcare Corporation (NYSE:THC) today reported a loss of $33 million, or $0.07 per share, for its fourth quarter of 2008, compared to a net loss of $75 million, or $0.16 per share, for its fourth quarter of 2007. Adjusted EBITDA, a non-GAAP term defined below, was $199 million for the fourth quarter of 2008, an increase of $43 million, or 27.6 percent, as compared to $156 million for the fourth quarter of 2007. On a same-hospital basis, adjusted EBITDA was $201 million, an increase of $43 million, or 27.2 percent, as compared to $158 million in the fourth quarter of 2007.

For the year 2008, net income was $25 million, or $0.05 per share, compared to a net loss of $89 million, or $0.19 per share for 2007. Adjusted EBITDA, a non-GAAP term defined below, was $732 million in 2008, compared to $657 million for 2007, an increase of $75 million, or 11.4 percent. The adjusted EBITDA margin for 2008 was 8.4 percent, an increase of 40 basis points from an adjusted EBITDA margin of 8.0 percent in 2007.


“Growth in paying volumes remained positive despite the challenges of a severe decline in the economy in the fourth quarter. Paying admissions grew by 0.1 percent and paying outpatient visits grew by 0.9 percent. We are particularly gratified by this growth in our outpatient business which had experienced negative volume growth in recent years,” said Trevor Fetter, president and chief executive officer. “We view this volume growth, in the context of a challenging economic environment, as compelling evidence that our strategies continue to prove effective in advancing the Company towards sustained profitability.”

“Surgeries grew by a very strong 2.1 percent in the fourth quarter, highlighting growth in a number of our higher priority, targeted service lines,” said Stephen L. Newman, M.D., chief operating officer. “This growth can, in part, be attributed to our continued success at expanding our active medical staff. In 2008, our active medical staff grew by 1,122 physicians or 9.0 percent. As this growth is net of attrition, we believe this expansion of our medical staff could be an important leading indicator of continuing volume growth. Since the beginning of 2007, we have grown the number of physicians on our active medical staff by 17.0 percent.”

“Both our fourth quarter and full year results benefited from continued strong pricing and solid cost control,” said Biggs C. Porter, chief financial officer. “We constrained growth in same-hospital controllable operating expense per adjusted patient day to just 0.8 percent. This focus on cost control made a significant contribution to improved profitability in the quarter, with our adjusted EBITDA margin rising to 9.1 percent. Our progress on pricing and cost efficiencies is expected to provide continuing benefits into 2009 including incremental cost efficiencies, which we expect to total approximately $150 million by year end. Although we now expect there may be increasing pressure on bad debt and commercial volumes in 2009, our outlook for 2009 adjusted EBITDA is in the range of $735 million to $800 million.”

Adjusted EBITDA

Adjusted EBITDA, a non-GAAP term defined below, was $199 million, or a margin of 9.1 percent of net operating revenues, in the fourth quarter of 2008. This represents an increase of $43 million, or 27.6 percent, from adjusted EBITDA of $156 million in the fourth quarter of 2007, and margin increase of 160 basis points as compared to an adjusted EBITDA margin of 7.5 percent in the fourth quarter of 2007.

Same-hospital adjusted EBITDA was $201 million in the fourth quarter of 2008, an increase of $43 million, or 27.2 percent, from the $158 million in the fourth quarter of 2007. Same-hospital adjusted EBITDA margin increased by 170 basis points to 9.3 percent in the fourth quarter of 2008 as compared to the same-hospital adjusted EBITDA margin of 7.6 percent in the fourth quarter of 2007. For 2008, same-hospital adjusted EBITDA was $752 million, an increase of $93 million, or 14.1 percent, as compared to $659 million for 2007.

Adjusted EBITDA is a non-GAAP term defined by the Company as net income (loss) before: (1) the cumulative effect of changes in accounting principle, net of tax; (2) income (loss) from discontinued operations, net of tax; (3) income tax (expense) benefit; (4) net gains (losses) on sales of investments; (5) minority interests; (6) investment earnings; (7) interest expense; (8) litigation and investigation (costs) benefit, net of insurance recoveries; (9) hurricane insurance recoveries, net of costs; (10) impairment of long-lived assets and goodwill and restructuring charges, net of insurance recoveries; (11) amortization; and (12) depreciation. A reconciliation of net income (loss) to adjusted EBITDA is provided in Table #1 at the end of this release.

Same-Hospital Data

Same-hospital continuing operations data excludes two hospitals: (1) Coastal Carolina Medical Center, which we acquired on June 30, 2007; and (2) Sierra Providence East Medical Center, in El Paso, which opened on May 21, 2008. Same-hospital continuing operations data is the primary form of tabular data presentation in the narrative sections of this document. There are currently 48 hospitals in same-hospital continuing operations. The Company intends to add Coastal Carolina Medical Center to same-hospital continuing operations beginning on January 1, 2009.

 

- 2 -


Total-hospital data, including the contribution of Coastal Carolina Medical Center and Sierra Providence East Medical Center, is provided in the tabular presentation of data at the end of this document. As a result of this approach, certain amounts in the narrative section of this document will not tie to amounts in the condensed consolidated statement of operations.

Admissions, Patient Days and Surgeries

 

     Same-Hospital
Continuing Operations
 

Admissions, Patient Days and Surgeries

   Q4’08    Q4’07    Change (%)  

Commercial Managed Care Admissions

   34,734    35,809    (3.0 )

Governmental Managed Care Admissions

   28,542    25,930    10.1  

Medicare Admissions

   39,452    40,419    (2.4 )

Medicaid Admissions

   16,102    16,502    (2.4 )

Uninsured Admissions

   5,957    6,331    (5.9 )

Charity Care Admissions

   2,269    2,293    (1.0 )

Other Admissions

   3,328    3,330    (0.1 )

Total Admissions

   130,384    130,614    (0.2 )

Paying Admissions (excludes Charity + Uninsured)

   122,158    121,990    0.1  

Charity Admissions + Uninsured Admissions

   8,226    8,624    (4.6 )

Admissions through Emergency Department

   73,570    72,106    2.0  

Commercial Managed Care Admits / Total Admits (%)

   26.6    27.4    (0.8 ) (a)

Emergency Department Admissions / Total Admits (%)

   56.4    55.2    1.2  (a)

Uninsured Admissions / Total Admissions (%)

   4.6    4.8    (0.2 ) (a)

Charity Admissions / Total Admissions (%)

   1.7    1.8    (0.1 ) (a)

Surgeries – Inpatient

   38,713    38,727    —    

Surgeries – Outpatient

   52,201    50,333    3.7  

Surgeries – Total

   90,914    89,060    2.1  

Patient Days – Total

   636,724    643,533    (1.1 )

Adjusted Patient Days (b)

   924,882    917,133    0.8  

Patient Days – Commercial Managed Care

   138,117    143,385    (3.7 )

Average Length of Stay (days)

   4.9    4.9    —    (a)

Adjusted Patient Admissions (b)

   190,535    187,589    1.6  

 

(a) This change is the difference between the Q4’08 and Q4’07 amounts shown
(b) “Adjusted Patient Days / Admissions” represents actual patient days / admissions adjusted to include outpatient services by multiplying actual patient days / admissions by the sum of gross inpatient revenues and outpatient revenues and dividing the results by gross inpatient revenues.

Our Florida and Central Regions achieved the strongest admissions growth in the quarter and our Central Region achieved fourth quarter growth that outperformed all but its third quarter results. Our California Region experienced a decline in admissions in the fourth quarter, which was its only quarter of negative growth in 2008. Both our Southern States Region and our Philadelphia Market had admissions declines in the fourth quarter.

While total same-hospital admissions declined by 0.2 percent in the fourth quarter, paying admissions grew by 0.1 percent. There was a 4.6 percent decline in uninsured and charity admissions.

Commercial managed care admissions declined by 3.0 percent relative to the fourth quarter of 2007, but improved its trend relative to the 3.4 percent decline reported in the third quarter of 2008. A decline in obstetrics volumes accounted for 58 percent of our decline in commercial admissions in the fourth quarter of 2008 compared to commercial admissions in the fourth quarter of 2007. Under our Targeted Growth Initiative we have deemphasized the obstetrics service line in a significant number of our hospitals.

Surgery growth remained strong supported by growth in outpatient surgeries of 3.7 percent. Inpatient surgeries were flat relative to the fourth quarter of 2007. Our Targeted Growth Initiative brought incremental focus to a number of the service lines that contributed to this growth in surgeries.

 

- 3 -


Outpatient Visits

 

Outpatient Visits

   Same-Hospital
Continuing Operations
 
   Q4’08    Q4’07    Change (%)  

Total OP Visits

   929,750    932,837    (0.3 )

Paying OP Visits (excludes Uninsured + Charity)

   830,633    823,364    0.9  

Uninsured OP Visits

   93,063    104,278    (10.8 )

Uninsured OP Visits / Total OP Visits (%)

   10.0    11.2    (1.2 (a)

Charity Care OP Visits

   6,054    5,195    16.5  

Charity Care OP Visits / Total OP Visits (%)

   0.7    0.6    0.1  (a)

OP Surgery Visits

   52,201    50,333    3.7  

Commercial Managed Care OP Visits

   355,424    356,303    (0.2 )

Commercial OP Visits / Total Visits (%)

   38.2    38.2    —    (a)

 

(a)    This change is the difference between the Q4’08 and Q4’07 amounts shown.

      

While total same-hospital outpatient visits declined by 0.3 percent, paying outpatient visits (excluding uninsured and charity outpatient visits) increased by 0.9 percent in the fourth quarter of 2008 as compared to the fourth quarter of 2007. Competition from physician-owned enterprises offering outpatient services continues to restrain our growth in outpatient volumes.

Our recent acquisitions of outpatient facilities added 2,053 outpatient visits in the fourth quarter of 2008. This source of increased outpatient visits was more than offset by 3,928 lost visits resulting from recent divestitures and the joint venturing of some of our existing outpatient facilities where Tenet has taken a minority interest. Excluding the impact of this resultant net loss of 1,875 outpatient visits from acquisitions and divestitures, outpatient visits in the fourth quarter of 2008 would have declined by 1,212 visits, or 0.1 percent.

Revenues

 

Revenues

($ in millions)

   Same-Hospital
Continuing Operations
 
   Q4’08    Q4’07    Change (%)  

Net Operating Revenues

   2,172    2,070    4.9  

Net Patient Revenue from Commercial Managed Care

   872    818    6.6  

Revenues from the Uninsured

   148    155    (4.5 )

Net operating revenues in the fourth quarter of 2008 include $8 million from the partial reversal of a $17 million unfavorable adjustment recorded in the second quarter of 2008 related to a graduate medical education reimbursement dispute at one of our California hospitals. Excluding this $8 million from net operating revenues for the fourth quarter of 2008, net operating revenues would have increased by $94 million, or 4.5 percent, compared to the fourth quarter of 2007. As the charge reversal was recorded in “Other Revenue”, our fourth quarter 2008 patient pricing statistics were unaffected.

Prior-year cost report adjustments contributed $2 million to net operating revenues in the fourth quarter of 2008. Prior-year cost report adjustments made no material contribution to net operating revenues in the fourth quarter of 2007.

 

- 4 -


Pricing

 

Pricing

($)

   Same-Hospital
Continuing Operations
   Q4’08    Q4’07    Change (%)

Net Inpatient Revenue per Admission

   11,052    10,665    3.6

Net Inpatient Revenue per Patient Day

   2,263    2,165    4.5

Net Outpatient Revenue per Visit

   691    646    7.0

Net Patient Revenue per Adjusted Patient Admission

   10,933    10,643    2.7

Net Patient Revenue per Adjusted Patient Day

   2,252    2,177    3.4

Managed Care: Net Inpatient Revenue per Admission

   11,803    11,284    4.6

Managed Care: Net Outpatient Revenue per Visit

   808    759    6.5

Pricing improvement was evident across all key metrics, primarily reflecting the improved terms of our commercial managed care contracts. Outpatient pricing again outpaced the growth in inpatient pricing due to an improving mix of procedures performed in our outpatient facilities. Our investment and development of higher-end procedures in both the surgery and imaging segments of our outpatient business, as well as recent acquisitions, have contributed to this improving mix.

Controllable Operating Expenses

 

Controllable Operating Expenses

   Same-Hospital
Continuing Operations
 
   Q4’08    Q4’07    Change (%)  

Salaries, Wages & Benefits ($mm)

   957    942    1.6  

Supplies ($mm)

   384    364    5.5  

Other Operating Expenses ($mm)

   467    473    (1.3 )

Total Controllable Operating Expenses ($mm)

   1,808    1,779    1.6  

Rent / Lease Expense (a) ($mm)

   35    34    2.9  

Unit Cost Statistics

        

Salaries, Wages & Benefits per Adjusted Patient Day ($)

   1,035    1,027    0.8  

Supplies per Adjusted Patient Day ($)

   415    397    4.5  

Other Operating Expenses per Adjusted Patient Day ($)

   505    516    (2.1 )

Total Controllable Operating Expenses per Adjusted Patient Day ($)

   1,955    1,940    0.8  

 

(a)      Included in Other Operating Expenses

        

On a per adjusted patient day basis, salaries, wages and benefits increased 0.8 percent in the fourth quarter of 2008 as compared to the fourth quarter of 2007. This increase is primarily due to merit increases for our employees, and increased health benefits costs, partially offset by a decline in full-time employee headcount, reduced contract labor expense, and improved worker’s compensation loss experience, and lower incentive compensation costs. Contract labor expense, which is included in salaries, wages and benefits, was $30 million in the fourth quarter of 2008, a decrease of $6 million, or 16.7 percent, as compared to the fourth quarter of 2007.

Supplies expense per adjusted patient day increased by 4.5 percent in the fourth quarter of 2008 as compared to the fourth quarter of 2007. The increase in supplies expense is primarily due to the increased number of surgeries as well as the costs of certain new, higher cost drugs. A portion of the increase in supplies expense is offset by revenue growth related to pass-through payments we receive from certain payers.

“Other Operating Expenses” per adjusted patient day decreased by 2.1 percent in the fourth quarter of 2008 as compared to the fourth quarter of 2007. Included in this decrease was a significant decline in malpractice expense. On a total hospital basis, malpractice expense declined from $36 million in the fourth quarter of 2007 to $18 million in the fourth quarter of 2007, a decline of $18 million, or 50.0 percent. This decrease is primarily attributable to improved claims experience and was partially offset by $4 million of incremental expenses related to a lower interest rate environment that increased the discounted present value of projected future liabilities. The

 

- 5 -


favorable impact of declining malpractice expense was partially offset by increases in other items including higher physician fees reflecting increases in Emergency Department on-call payments, increases in costs of contracted services, as well as repair and maintenance costs. Declining consulting costs also had a favorable impact on “Other Operating Expenses.”

Provision for Doubtful Accounts

 

Bad Debt

   Same-Hospital
Continuing Operations
 
   Q4’08    Q4’07    Change (%)  

Provision for Doubtful Accounts (“Bad Debt”) ($mm)

   163    133    22.6  

Bad Debt / Net Operating Revenues (%)

   7.5    6.4    1.1  (a)

Collection Rate from Self-Pay (%)

   33    35    (2 (a)

Collection Rate from Managed Care Payers (%)

   98    98    —    (a)

 

(a)    This change is the difference between the Q4’08 and Q4’07 amounts shown.

      

Bad debt expense increased by $30 million, or 22.6 percent, despite declines in uninsured admissions and outpatient visits of 5.9 percent and 10.8 percent, respectively. The increase in bad debt expense resulted from the decline in our self-pay collection rate which declined to approximately 33 percent from 35 percent in the fourth quarter of 2007, higher pricing, higher patient insurance deductibles, and a favorable adjustment to bad debt expense in the fourth quarter of 2007 which did not recur.

Accounts Receivable

Consolidated accounts receivable were $1.337 billion at December 31, 2008, and $1.356 billion at September 30, 2008. Accounts receivable days outstanding from continuing operations were 50 days at December 31, 2008, compared to 51 days at September 30, 2008 and 52 days at December 31, 2007.

Cash Flow

Cash and cash equivalents were $507 million at December 31, 2008, a decrease of $5 million from $512 million at September 30, 2008. Adjusted Free Cash Flow, a non-GAAP term defined below, was negative $29 million in the fourth quarter of 2008 compared to negative $164 million in the fourth quarter of 2007.

Adjusted Free Cash Flow, a non-GAAP term, is defined by the Company as cash flows provided by (used in) operating activities less (1) capital expenditures in continuing operations, (2) new and replacement hospital construction expenditures, (3) income tax refunds (payments), (4) net cash provided by (used in) operating activities from discontinued operations, and (5) payments against reserves for restructuring charges, litigation costs and settlements. The reconciliation of net cash provided by (used in) operating activities, the most comparable GAAP term, to Adjusted Free Cash Flow is provided in Table #2 at the end of this release.

Significant cash flow items in the fourth quarter of 2008 included:

 

  (1) Capital expenditures of $134 million, consisting of $130 million in continuing operations and $4 million in discontinued operations;

 

  (2) Interest payments of $70 million;

 

  (3) $22 million in principal payments (excluding interest of $2 million) classified as operating cash outflows from continuing operations related to our 2006 civil settlement with the federal government, these principal payments totaled $88 million for the full year 2008;

 

  (4) A $39 million decline in the cash and cash equivalents balance related to our Medicare HMO insurance subsidiary operating in Louisiana, primarily due to the timing of monthly payments from CMS, which is classified as a discontinued operations cash outflow from operations;

 

  (5) Cash distributions of $34 million we received related to our investment in the Reserve Yield Plus Fund, which are classified as investing activity cash flows; and

 

- 6 -


  (6) Insurance recoveries of $14 million related to our December 2004 Redding Medical Center litigation settlement; based on the components of the recoveries, $5 million was classified as operating cash flows from continuing operations and $9 million was classified as operating cash flows from discontinued operations.

Outlook for 2009

The Company’s outlook for 2009 is materially dependent on a number of items which are difficult to project given the uncertain macro-economic environment. Among the most important of these items are aggregate patient volumes, payer and patient mix, and bad debt expense.

As a basis for our 2009 Outlook, we have assumed same-hospital admissions growth of approximately flat to one percent, and same-hospital outpatient visit growth of flat to one percent. In 2008, same-hospital admissions grew by 1.2 percent and same-hospital outpatient visits declined by 0.1 percent.

Based on these volume assumptions, the 2009 outlook for growth in net operating revenues is in the range of 4 to 6 percent. This is consistent with an outlook for total-company net operating revenues in the range $9.0 billion to $9.2 billion. Total-company net operating revenues were $8.663 billion in 2008 representing growth of 6.1 percent over 2007, or growth of 5.6 percent on a same-hospital basis.

The outlook for growth in controllable operating expenses per adjusted patient day is in the range of 2 to 3 percent for 2009. This compares to 2.6 percent growth in same-hospital controllable operating expenses per adjusted patient day in 2008. On a total-company basis, this corresponds to an expected range for 2009 controllable operating expenses of $7.5 billion to $7.6 billion. Our 2009 outlook reflects the Company’s expectations for continued cost efficiencies, including the Company’s recent initiatives targeting a reduction of approximately $150 million in gross cost savings and the favorable impact of enhanced operating leverage that is expected to result from the assumed growth in patient volumes.

The 2009 outlook for total-company bad debt expense is in the range of 8.3 to 9.3 percent of net operating revenues, or total company bad debt expense in the range of $750 million to $850 million. In 2008, total-company bad debt expense was $632 million, or 7.3 percent of net operating revenues. In the fourth quarter of 2008, total-company bad debt ratio was 7.6 percent.

Adjusted EBITDA (a non-GAAP term reconciled to net loss as defined by GAAP in Table #3 at the end of this release) is expected to be in the range of $735 million to $800 million in 2009, on a total-company basis. Based on the outlook for net operating revenues cited above, this corresponds to an adjusted EBITDA margin range of 8.2 to 8.7 percent. In 2008, Tenet’s adjusted EBITDA was $732 million, for an adjusted EBITDA margin of 8.4 percent.

The outlook for depreciation and amortization expense in 2009 is approximately $400 million to $420 million, and the 2009 outlook for interest expense is approximately $450 million to $470 million, net of investment earnings and minority interest. This estimate of 2009 interest expense includes an estimated impact from Tenet’s note exchange offer of $50 million to $60 million. The note exchange offer has an anticipated completion date of early March.

Tenet’s 2009 outlook for income (loss) from continuing operations before income taxes ranges from a loss of $15 million to income of $135 million. Excluding four items in Table #3 at the end of this release ((1)net gains (losses) on sales of investment; (2) litigation and investigation costs; (3) gain on exchange of long-term debt; (4) impairment of long-lived assets and goodwill and restructuring charges), the 2009 outlook for loss from continuing operations before income taxes ranges from a loss of $135 million to a loss of $70 million. Using an assumption of 37.1 percent for normalized 2009 income taxes, results in an income tax benefit of $50 million to $26 million and average expected shares outstanding of 484 million, the 2009 outlook for normalized loss per share from continuing operations, after excluding the items listed in Table 3 at the end of this release, is in the range of a loss $0.18 to a loss of $0.09 per share.

 

- 7 -


The Company’s 2009 Outlook includes an expectation of adjusted net cash provided by operating activities from continuing operations to be in the range of $240 million to $315 million, which the Company defines to exclude income tax payments/refunds, litigation and restructuring payments, and net cash provided by (used in) operating activities from discontinued operations.

Capital expenditures for continuing operations are expected to be in the range of $400 million to $450 million in 2009.

Adjusted free cash flow from continuing operations for 2009 (based on adjustments provided in Table 4 at the end of this release) is expected to be in the range of negative $160 million to $135 million.

The outlook range for cash and cash equivalents at December 31, 2009 is $450 million to $550 million. This assumes the sale of USC Hospital and other cash initiatives aggregating to approximately $308 million to $343 million.

A reconciliation of outlook adjusted EBITDA to outlook net income (loss) for year ending December 31, 2009 is provided in Table 3; and a reconciliation of outlook adjusted net cash provided by operating activities, and outlook adjusted free cash flow from continuing operations to outlook net cash provided by operating activities for the year ending December 31, 2009 is provided in Table 4 at the end of this release.

Management’s Webcast Discussion of Fourth Quarter Results

Tenet management will discuss fourth quarter 2008 results on a webcast scheduled to begin at 10:00 AM (ET) on February 24, 2009. This webcast may be accessed through Tenet’s website at www.tenethealth.com. A set of slides, which may be referred to during management’s remarks, will be posted to the Company’s website at approximately 7:30 AM (ET).

Tenet Healthcare Corporation, through its subsidiaries, owns and operates acute care hospitals and related ancillary health care businesses, which include ambulatory surgery centers and diagnostic imaging centers. Tenet is committed to providing high quality care to patients in the communities we serve. Tenet can be found on the World Wide Web at www.tenethealth.com.

# # #

Some of the statements in this release may constitute forward-looking statements. Such forward-looking statements are based on our current expectations and could be affected by numerous factors and are subject to various risks and uncertainties discussed in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended Dec. 31, 2008, our quarterly reports on Form 10-Q, and periodic reports on Form 8-K. Do not rely on any forward-looking statement, as we cannot predict or control many of the factors that ultimately may affect our ability to achieve the results estimated. We make no promise to update any forward-looking statement, whether as a result of changes in underlying factors, new information, future events or otherwise.

 

- 8 -


TENET HEALTHCARE CORPORATION

CONSOLIDATED OPERATIONS DATA

(Unaudited)

 

(Dollars in millions except per share amounts)    Three Months Ended December 31,  
     2008     %     2007     %     Change  

Net operating revenues

   $ 2,195     100.0 %   $ 2,077     100.0 %   5.7 %

Operating expenses:

          

Salaries, wages and benefits

     (967 )   (44.1 )%     (946 )   (45.5 )%   2.2 %

Supplies

     (388 )   (17.7 )%     (365 )   (17.6 )%   6.3 %

Provision for doubtful accounts

     (166 )   (7.6 )%     (134 )   (6.5 )%   23.9 %

Other operating expenses, net

     (475 )   (21.6 )%     (476 )   (22.9 )%   (0.2 )%

Depreciation

     (85 )   (3.9 )%     (78 )   (3.7 )%   9.0 %

Amortization

     (11 )   (0.5 )%     (7 )   (0.3 )%   57.1 %

Impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries

     (14 )   (0.6 )%     (25 )   (1.2 )%  

Hurricane insurance recoveries, net of costs

     —       —         3     0.1 %  

Litigation and investigation (costs) benefit, net of insurance recoveries

     4     0.2 %     (12 )   (0.6 )%  
                              

Operating income

     93     4.2 %     37     1.8 %  

Interest expense

     (106 )       (104 )    

Investment earnings

     1         11      

Minority interests

     (3 )       (2 )    

Net losses on sales of investments

     (1 )       —        
                      

Loss from continuing operations, before income taxes

     (16 )       (58 )    

Income tax (expense) benefit

     6         (20 )    
                      

Loss from continuing operations, before discontinued operations

     (10 )       (78 )    

Discontinued operations:

          

Income from operations

     25         26      

Impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries

     (55 )       (22 )    

Net gains (losses) on sales of facilities

     1         (4 )    

Income tax benefit

     6         3      
                      

Income (loss) from discontinued operations, net of tax

     (23 )       3      
                      

Net loss

   $ (33 )     $ (75 )    
                      

Earnings (loss) per share

          

Basic and diluted

          

Continuing operations

   $ (0.02 )     $ (0.16 )    

Discontinued operations

     (0.05 )       —        
                      
   $ (0.07 )     $ (0.16 )    
                      

Weighted average shares and dilutive securities outstanding (in thousands):

     477,126         474,286      

 

- 9 -


TENET HEALTHCARE CORPORATION

CONSOLIDATED OPERATIONS DATA

(Unaudited)

 

(Dollars in millions except per share amounts)    Year Ended December 31,  
     2008     %     2007     %     Change  

Net operating revenues

   $ 8,663     100.0 %   $ 8,167     100.0 %   6.1 %

Operating expenses:

          

Salaries, wages and benefits

     (3,816 )   (44.0 )%     (3,655 )   (44.7 )%   4.4 %

Supplies

     (1,528 )   (17.6 )%     (1,418 )   (17.4 )%   7.8 %

Provision for doubtful accounts

     (632 )   (7.3 )%     (561 )   (6.9 )%   12.7 %

Other operating expenses, net

     (1,955 )   (22.6 )%     (1,876 )   (22.9 )%   4.2 %

Depreciation

     (335 )   (3.9 )%     (308 )   (3.8 )%   8.8 %

Amortization

     (38 )   (0.4 )%     (30 )   (0.4 )%   26.7 %

Impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries

     (18 )   (0.2 )%     (49 )   (0.6 )%  

Hurricane insurance recoveries, net of costs

     —       —         3     —   %  

Litigation and investigation costs, net of insurance recoveries

     (41 )   (0.5 )%     (13 )   (0.1 )%  
                              

Operating income

     300     3.5 %     260     3.2 %  

Interest expense

     (418 )       (419 )    

Investment earnings

     22         47      

Minority interests

     (6 )       (4 )    

Net gains on sales of investments

     139         —        
                      

Income (loss) from continuing operations, before income taxes

     37         (116 )    

Income tax benefit

     25         63      
                      

Income (loss) from continuing operations, before discontinued operations

     62         (53 )    

Discontinued operations:

          

Income (loss) from operations

     6         (3 )    

Impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries

     (93 )       (40 )    

Net gains (losses) on sales of facilities

     6         (8 )    

Litigation settlements, net of insurance recoveries

     39         —        

Income tax benefit

     5         15      
                      

Loss from discontinued operations, net of tax

     (37 )       (36 )    
                      

Net income (loss)

   $ 25       $ (89 )    
                      

Earnings (loss) per share

          

Basic and diluted

          

Continuing operations

   $ 0.13       $ (0.11 )    

Discontinued operations

     (0.08 )       (0.08 )    
                      
   $ 0.05       $ (0.19 )    
                      

Weighted average shares and dilutive securities outstanding (in thousands):

     478,606         473,405      

 

- 10 -


TENET HEALTHCARE CORPORATION

BALANCE SHEET DATA

(Unaudited)

 

(Dollars in millions)    December 31,
2008
    December 31,
2007
 

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 507     $ 572  

Investments in Reserve Yield Plus Fund

     14       —    

Investments in marketable debt securities

     2       20  

Accounts receivable, less allowance for doubtful accounts

     1,337       1,385  

Inventories of supplies, at cost

     161       183  

Income tax receivable

     6       7  

Deferred income taxes

     82       87  

Assets held for sale

     310       51  

Other current assets

     290       255  
                

Total current assets

     2,709       2,560  

Investments and other assets

     242       288  

Property and equipment, at cost, less accumulated depreciation and amortization

     4,291       4,645  

Goodwill

     609       607  

Other intangible assets, at cost, less accumulated amortization

     323       293  
                

Total assets

   $ 8,174     $ 8,393  
                

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

Current liabilities:

    

Current portion of long-term debt

   $ 2     $ 1  

Accounts payable

     686       780  

Accrued compensation and benefits

     414       393  

Professional and general liability reserves

     127       161  

Accrued interest payable

     125       126  

Accrued legal settlement costs

     168       119  

Other current liabilities

     427       468  
                

Total current liabilities

     1,949       2,048  

Long-term debt, net of current portion

     4,778       4,771  

Professional and general liability reserves

     536       555  

Accrued legal settlement costs

     72       163  

Other long-term liabilities and minority interests

     635       683  

Deferred income taxes

     101       119  
                

Total liabilities

     8,071       8,339  

Commitments and contingencies

    

Shareholders’ equity:

    

Common stock

     26       26  

Additional paid-in capital

     4,445       4,412  

Accumulated other comprehensive loss

     (37 )     (28 )

Accumulated deficit

     (2,852 )     (2,877 )

Less common stock in treasury, at cost

     (1,479 )     (1,479 )
                

Total shareholders’ equity

     103       54  
                

Total liabilities and shareholders’ equity

   $ 8,174     $ 8,393  
                

 

- 11 -


TENET HEALTHCARE CORPORATION

CASH FLOW DATA

(Unaudited)

 

(Dollars in millions)    Year Ended
December 31,
 
     2008     2007  

Net income (loss)

   $ 25     $ (89 )

Adjustments to reconcile net income (loss) to net cash from operating activities:

    

Depreciation and amortization

     373       338  

Provision for doubtful accounts

     632       561  

Net gains on sales of investments

     (139 )     —    

Deferred income tax expense (benefit)

     (13 )     2  

Stock-based compensation expense

     33       40  

Impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries

     18       49  

Litigation and investigation costs, net of insurance recoveries

     41       13  

Pretax loss from discontinued operations

     42       51  

Other items, net

     11       (11 )

Changes in cash from changes in operating assets and liabilities:

    

Accounts receivable

     (651 )     (638 )

Inventories and other current assets

     (2 )     (28 )

Income taxes

     (21 )     83  

Accounts payable, accrued expenses and other current liabilities

     (29 )     (94 )

Other long-term liabilities

     (36 )     39  

Payments against reserves for restructuring charges and litigation costs and settlements

     (100 )     (70 )

Net cash provided by operating activities from discontinued operations, excluding income taxes

     24       80  
                

Net cash provided by operating activities

     208       326  

Cash flows from investing activities:

    

Purchases of property and equipment:

    

Continuing operations

     (452 )     (622 )

Discontinued operations

     (20 )     (54 )

Construction of new and replacement hospitals

     (75 )     (67 )

Purchase of business or joint venture interest

     (92 )     (36 )

Proceeds from sales of facilities and other assets – discontinued operations

     160       91  

Proceeds from sales of marketable securities, long-term investments and other assets

     224       706  

Purchases of marketable securities

     (26 )     (652 )

Reclassification of investments in Reserve Yield Plus Fund out of cash equivalents

     (14 )     —    

Proceeds from hospital authority bonds

     8       31  

Proceeds from cash surrender value of insurance policies

     11       82  

Insurance recoveries for property damage

     1       6  

Other items, net

     1       (5 )
                

Net cash used in investing activities

     (274 )     (520 )

Cash flows from financing activities:

    

Repayments of borrowings

     (1 )     (22 )

Other items, net

     2       4  
                

Net cash provided by (used in) financing activities

     1       (18 )
                

Net decrease in cash and cash equivalents

     (65 )     (212 )

Cash and cash equivalents at beginning of period

     572       784  
                

Cash and cash equivalents at end of period

   $ 507     $ 572  
                

Supplemental disclosures:

    

Interest paid, net of capitalized interest

   $ (391 )   $ (395 )

Income tax (payments) refunds, net

   $ (4 )   $ 162  

 

- 12 -


TENET HEALTHCARE CORPORATION

SELECTED STATISTICS – CONTINUING SAME HOSPITALS

(Unaudited)

 

(Dollars in millions except per patient day,

per admission and per visit amounts)

   Three Months Ended December 31,     Year Ended December 31,  
   2008     2007     Change     2008     2007     Change  

Net inpatient revenues

   $ 1,441     $ 1,393     3.4 %   $ 5,724     $ 5,485     4.4 %

Net outpatient revenues

   $ 642     $ 603     6.5 %   $ 2,568     $ 2,376     8.1 %

Number of general hospitals (at end of period)

     48       48     —   *     48       48     —   *

Licensed beds (at end of period)

     13,411       13,454     (0.3 )%     13,411       13,454     (0.3 )%

Average licensed beds

     13,396       13,454     (0.4 )%     13,398       13,431     (0.2 )%

Utilization of licensed beds

     51.7 %     52.0 %   (0.3 )% *     53.2 %     53.0 %   0.2 % *

Patient days

     636,724       643,533     (1.1 )%     2,610,199       2,599,420     0.4 %

Adjusted patient days

     924,882       917,133     0.8 %     3,759,463       3,695,444     1.7 %

Net inpatient revenue per patient day

   $ 2,263     $ 2,165     4.5 %   $ 2,193     $ 2,110     3.9 %

Admissions

     130,384       130,614     (0.2 )%     527,148       521,028     1.2 %

Adjusted patient admissions

     190,535       187,589     1.6 %     764,490       745,917     2.5 %

Net inpatient revenue per admission

   $ 11,052     $ 10,665     3.6 %   $ 10,858     $ 10,527     3.1 %

Average length of stay (days)

     4.9       4.9     —   *     5.0       5.0     —   *

Surgeries

     90,914       89,060     2.1 %     361,013       356,664     1.2 %

Net outpatient revenue per visit

   $ 691     $ 646     7.0 %   $ 681     $ 629     8.3 %

Outpatient visits

     929,750       932,837     (0.3 )%     3,773,459       3,776,219     (0.1 )%

Sources of net patient revenue

            

Medicare

     25.5 %     25.5 %   —   % *     25.4 %     25.9 %   (0.5 )% *

Medicaid

     8.3 %     8.9 %   (0.6 )% *     8.4 %     8.8 %   (0.4 )% *

Managed care governmental

     14.0 %     12.9 %   1.1 % *     13.5 %     12.1 %   1.4 % *

Managed care commercial

     41.9 %     41.0 %   0.9 % *     41.3 %     41.0 %   0.3 % *

Indemnity, self-pay and other

     10.3 %     11.7 %   (1.4 )% *     11.4 %     12.2 %   (0.8 )% *

 

* This change is the difference between the 2008 and 2007 amounts shown

 

- 13 -


TENET HEALTHCARE CORPORATION

SELECTED STATISTICS – CONTINUING TOTAL HOSPITALS

(Unaudited)

 

(Dollars in millions except per patient day,

per admission and per visit amounts)

   Three Months Ended December 31,     Year Ended December 31,  
   2008     2007     Change     2008     2007     Change  

Net inpatient revenues

   $ 1,452     $ 1,397     3.9 %   $ 5,749     $ 5,492     4.7 %

Net outpatient revenues

   $ 654     $ 608     7.6 %   $ 2,599     $ 2,385     9.0 %

Number of general hospitals (at end of period)

     50       49     1 *     50       49     1 *

Licensed beds (at end of period)

     13,562       13,495     0.5 %     13,562       13,495     0.5 %

Average licensed beds

     13,547       13,495     0.4 %     13,512       13,455     0.4 %

Utilization of licensed beds

     51.5 %     52.0 %   (0.5 )% *     53.0 %     53.0 %   —   *

Patient days

     641,594       644,959     (0.5 )%     2,622,227       2,602,735     0.7 %

Adjusted patient days

     934,829       921,434     1.5 %     3,788,063       3,704,837     2.2 %

Net inpatient revenue per patient day

   $ 2,263     $ 2,166     4.5 %   $ 2,192     $ 2,110     3.9 %

Admissions

     131,693       130,927     0.6 %     530,303       521,735     1.6 %

Adjusted patient admissions

     193,108       188,530     2.4 %     771,704       747,920     3.2 %

Net inpatient revenue per admission

   $ 11,026     $ 10,670     3.3 %   $ 10,841     $ 10,526     3.0 %

Average length of stay (days)

     4.9       4.9     —   *     4.9       5.0     (0.1 ) *

Surgeries

     91,470       89,091     2.7 %     362,663       357,173     1.5 %

Net outpatient revenue per visit

   $ 691     $ 645     7.1 %   $ 679     $ 628     8.1 %

Outpatient visits

     946,322       942,849     0.4 %     3,828,079       3,796,624     0.8 %

Sources of net patient revenue

            

Medicare

     25.5 %     25.4 %   0.1 % *     25.4 %     25.9 %   (0.5 )% *

Medicaid

     8.2 %     8.7 %   (0.5 )% *     8.4 %     8.8 %   (0.4 )% *

Managed care governmental

     14.1 %     12.9 %   1.2 % *     13.5 %     12.1 %   1.4 % *

Managed care commercial

     41.8 %     41.3 %   0.5 % *     41.3 %     41.0 %   0.3 % *

Indemnity, self-pay and other

     10.4 %     11.7 %   (1.3 )% *     11.4 %     12.2 %   (0.8 )% *

 

* This change is the difference between the 2008 and 2007 amounts shown

 

- 14 -


TENET HEALTHCARE CORPORATION

CONSOLIDATED OPERATIONS DATA

Fiscal 2008 by Calendar Quarter

(Unaudited)

 

(Dollars in millions except per share amounts)    Three Months Ended     Year Ended
12/31/08
 
   3/31/08     6/30/08     9/30/08     12/31/08    

Net operating revenues

   $ 2,178     $ 2,132     $ 2,158     $ 2,195     $ 8,663  

Operating expenses:

          

Salaries, wages and benefits

     (954 )     (943 )     (952 )     (967 )     (3,816 )

Supplies

     (379 )     (381 )     (380 )     (388 )     (1,528 )

Provision for doubtful accounts

     (147 )     (153 )     (166 )     (166 )     (632 )

Other operating expenses, net

     (483 )     (493 )     (504 )     (475 )     (1,955 )

Depreciation

     (82 )     (84 )     (84 )     (85 )     (335 )

Amortization

     (8 )     (9 )     (10 )     (11 )     (38 )

Impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries

     (1 )     (2 )     (1 )     (14 )     (18 )

Litigation and investigation (costs) benefit, net of insurance recoveries

     (47 )     (3 )     5       4       (41 )
                                        

Operating income

     77       64       66       93       300  

Interest expense

     (104 )     (102 )     (106 )     (106 )     (418 )

Investment earnings

     5       4       12       1       22  

Minority interests

     (1 )     —         (2 )     (3 )     (6 )

Net gains (losses) on sales of investments

     —         —         140       (1 )     139  
                                        

Income (loss) from continuing operations, before income taxes

     (23 )     (34 )     110       (16 )     37  

Income tax (expense) benefit

     (1 )     16       4       6       25  
                                        

Income (loss) from continuing operations, before discontinued operations

     (24 )     (18 )     114       (10 )     62  

Discontinued operations:

          

Income (loss) from operations

     5       5       (29 )     25       6  

Impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries

     (10 )     (7 )     (21 )     (55 )     (93 )

Net gains (losses) on sales of facilities

     —         8       (3 )     1       6  

Litigation settlements, net of insurance recoveries

     —         —         39       —         39  

Income tax (expense) benefit

     (2 )     (3 )     4       6       5  
                                        

Income (loss) from discontinued operations, net of tax

     (7 )     3       (10 )     (23 )     (37 )
                                        

Net income (loss)

   $ (31 )   $ (15 )   $ 104     $ (33 )   $ 25  
                                        

Earnings (loss) per share
Basic and diluted

          

Continuing operations

   $ (0.05 )   $ (0.04 )   $ 0.24     $ (0.02 )   $ 0.13  

Discontinued operations

     (0.01 )     0.01       (0.02 )     (0.05 )     (0.08 )
                                        
   $ (0.06 )   $ (0.03 )   $ 0.22     $ (0.07 )   $ 0.05  
                                        

Weighted average shares and dilutive securities outstanding (in thousands):

     475,066       476,308       480,789       477,126       478,606  

 

- 15 -


TENET HEALTHCARE CORPORATION

SELECTED STATISTICS – CONTINUING SAME HOSPITALS

Fiscal 2008 by Calendar Quarter

(Unaudited)

 

(Dollars in millions except per patient day,

per admission and per visit amounts)

   Three Months Ended     Year Ended
12/31/08
 
   3/31/08     6/30/08     9/30/08     12/31/08    

Net inpatient revenues

   $ 1,476     $ 1,401     $ 1,406     $ 1,441     $ 5,724  

Net outpatient revenues

   $ 624     $ 649     $ 653     $ 642     $ 2,568  

Number of general hospitals (at end of period)

     48       48       48       48       48  

Licensed beds (at end of period)

     13,397       13,394       13,380       13,411       13,411  

Average licensed beds

     13,416       13,396       13,385       13,396       13,398  

Utilization of licensed beds

     57.0 %     53.0 %     51.3 %     51.7 %     53.2 %

Patient days

     695,812       646,521       631,142       636,724       2,610,199  

Adjusted patient days

     978,880       934,017       921,684       924,882       3,759,463  

Net inpatient revenue per patient day

   $ 2,121     $ 2,167     $ 2,228     $ 2,263     $ 2,193  

Admissions

     136,765       130,423       129,576       130,384       527,148  

Adjusted patient admissions

     193,599       189,787       190,569       190,535       764,490  

Net inpatient revenue per admission

   $ 10,792     $ 10,742     $ 10,851     $ 11,052     $ 10,858  

Average length of stay (days)

     5.1       5.0       4.9       4.9       5.0  

Surgeries

     87,774       91,454       90,871       90,914       361,013  

Net outpatient revenue per visit

   $ 653     $ 687     $ 692     $ 691     $ 681  

Outpatient visits

     955,386       944,913       943,410       929,750       3,773,459  

Sources of net patient revenue

          

Medicare

     26.2 %     25.0 %     25.0 %     25.5 %     25.4 %

Medicaid

     8.5 %     8.4 %     8.6 %     8.3 %     8.4 %

Managed care governmental

     13.4 %     13.2 %     13.4 %     14.0 %     13.5 %

Managed care commercial

     40.1 %     41.9 %     41.5 %     41.9 %     41.3 %

Indemnity, self-pay and other

     11.8 %     11.5 %     11.5 %     10.3 %     11.4 %

 

- 16 -


TENET HEALTHCARE CORPORATION

SELECTED STATISTICS – CONTINUING TOTAL HOSPITALS

Fiscal 2008 by Calendar Quarter

(Unaudited)

 

(Dollars in millions except per patient day,

per admission and per visit amounts)

   Three Months Ended     Year Ended
12/31/08
 
   3/31/08     6/30/08     9/30/08     12/31/08    

Net inpatient revenues

   $ 1,478     $ 1,405     $ 1,414     $ 1,452     $ 5,749  

Net outpatient revenues

   $ 627     $ 654     $ 664     $ 654     $ 2,599  

Number of general hospitals (at end of period)

     49       50       50       50       50  

Licensed beds (at end of period)

     13,438       13,545       13,531       13,562       13,562  

Average licensed beds

     13,457       13,510       13,536       13,547       13,512  

Utilization of licensed beds

     56.9 %     52.8 %     51.0 %     51.5 %     53.0 %

Patient days

     697,274       648,604       634,755       641,594       2,622,227  

Adjusted patient days

     983,127       939,726       930,381       934,829       3,788,063  

Net inpatient revenue per patient day

   $ 2,120     $ 2,166     $ 2,228     $ 2,263     $ 2,192  

Admissions

     137,107       130,958       130,545       131,693       530,303  

Adjusted patient admissions

     194,592       191,205       192,799       193,108       771,704  

Net inpatient revenue per admission

   $ 10,780     $ 10,729     $ 10,832     $ 11,026     $ 10,841  

Average length of stay (days)

     5.1       5.0       4.9       4.9       4.9  

Surgeries

     88,015       91,771       91,407       91,470       362,663  

Net outpatient revenue per visit

   $ 650     $ 683     $ 692     $ 691     $ 679  

Outpatient visits

     965,200       957,335       959,222       946,322       3,828,079  

Sources of net patient revenue

          

Medicare

     26.2 %     24.9 %     25.0 %     25.5 %     25.4 %

Medicaid

     8.5 %     8.4 %     8.6 %     8.2 %     8.4 %

Managed care governmental

     13.4 %     13.2 %     13.3 %     14.1 %     13.5 %

Managed care commercial

     40.1 %     41.8 %     41.5 %     41.8 %     41.3 %

Indemnity, self-pay and other

     11.8 %     11.7 %     11.6 %     10.4 %     11.4 %

 

- 17 -


TENET HEALTHCARE CORPORATION

CONSOLIDATED OPERATIONS DATA

Fiscal 2007 by Calendar Quarter

(Unaudited)

 

(Dollars in millions except per share amounts)    Three Months Ended     Year Ended
12/31/07
 
   3/31/07     6/30/07     9/30/07     12/31/07    

Net operating revenues

   $ 2,047     $ 2,002     $ 2,041     $ 2,077     $ 8,167  

Operating expenses:

          

Salaries, wages and benefits

     (915 )     (888 )     (906 )     (946 )     (3,655 )

Supplies

     (357 )     (349 )     (347 )     (365 )     (1,418 )

Provision for doubtful accounts

     (133 )     (139 )     (155 )     (134 )     (561 )

Other operating expenses, net

     (462 )     (469 )     (469 )     (476 )     (1,876 )

Depreciation

     (76 )     (77 )     (77 )     (78 )     (308 )

Amortization

     (7 )     (9 )     (7 )     (7 )     (30 )

Impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries

     (3 )     (8 )     (13 )     (25 )     (49 )

Hurricane insurance recoveries, net of costs

     —         —         —         3       3  

Litigation and investigation (costs) benefit, net of insurance recoveries

     1       1       (3 )     (12 )     (13 )
                                        

Operating income

     95       64       64       37       260  

Interest expense

     (105 )     (105 )     (105 )     (104 )     (419 )

Investment earnings

     11       15       10       11       47  

Minority interests

     (2 )     —         —         (2 )     (4 )
                                        

Loss from continuing operations, before income taxes

     (1 )     (26 )     (31 )     (58 )     (116 )

Income tax (expense) benefit

     90       3       (10 )     (20 )     63  
                                        

Income (loss) from continuing operations, before discontinued operations

     89       (23 )     (41 )     (78 )     (53 )

Discontinued operations:

          

Income (loss) from operations

     (19 )     (5 )     (5 )     26       (3 )

Impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries

     (9 )     (3 )     (6 )     (22 )     (40 )

Net gains (losses) on sales of facilities

     (1 )     2       (5 )     (4 )     (8 )

Income tax (expense) benefit

     15       (1 )     (2 )     3       15  
                                        

Income (loss) from discontinued operations, net of tax

     (14 )     (7 )     (18 )     3       (36 )
                                        

Net income (loss)

   $ 75     $ (30 )   $ (59 )   $ (75 )   $ (89 )
                                        

Earnings (loss) per share
Basic and diluted

          

Continuing operations

   $ 0.19     $ (0.05 )   $ (0.08 )   $ (0.16 )   $ (0.11 )

Discontinued operations

     (0.03 )     (0.01 )     (0.04 )     —         (0.08 )
                                        
   $ 0.16     $ (0.06 )   $ (0.12 )   $ (0.16 )   $ (0.19 )
                                        

Weighted average shares and dilutive securities outstanding (in thousands):

     474,326       473,212       473,984       474,286       473,405  

 

- 18 -


TENET HEALTHCARE CORPORATION

SELECTED STATISTICS – CONTINUING SAME HOSPITALS

Fiscal 2007 by Calendar Quarter

(Unaudited)

 

(Dollars in millions except per patient day,

per admission and per visit amounts)

   Three Months Ended     Year Ended
12/31/07
 
   3/31/07     6/30/07     9/30/07     12/31/07    

Net inpatient revenues

   $ 1,390     $ 1,341     $ 1,361     $ 1,393     $ 5,485  

Net outpatient revenues

   $ 580     $ 593     $ 600     $ 603     $ 2,376  

Number of general hospitals (at end of period)

     48       48       48       48       48  

Licensed beds (at end of period)

     13,424       13,417       13,424       13,454       13,454  

Average licensed beds

     13,417       13,427       13,424       13,454       13,431  

Utilization of licensed beds

     56.9 %     52.1 %     51.1 %     52.0 %     53.0 %

Patient days

     687,564       636,980       631,343       643,533       2,599,420  

Adjusted patient days

     960,155       912,511       905,645       917,133       3,695,444  

Net inpatient revenue per patient day

   $ 2,022     $ 2,105     $ 2,156     $ 2,165     $ 2,110  

Admissions

     135,481       127,560       127,373       130,614       521,028  

Adjusted patient admissions

     190,260       183,960       184,108       187,589       745,917  

Net inpatient revenue per admission

   $ 10,260     $ 10,512     $ 10,685     $ 10,665     $ 10,527  

Average length of stay (days)

     5.1       5.0       5.0       4.9       5.0  

Surgeries

     88,963       88,792       89,849       89,060       356,664  

Net outpatient revenue per visit

   $ 601     $ 627     $ 643     $ 646     $ 629  

Outpatient visits

     964,700       945,369       933,313       932,837       3,776,219  

Sources of net patient revenue

          

Medicare

     27.5 %     25.2 %     25.3 %     25.5 %     25.9 %

Medicaid

     7.3 %     9.5 %     9.5 %     8.9 %     8.8 %

Managed care governmental

     12.7 %     11.3 %     11.4 %     12.9 %     12.1 %

Managed care commercial

     40.8 %     41.1 %     41.2 %     41.0 %     41.0 %

Indemnity, self-pay and other

     11.7 %     12.9 %     12.6 %     11.7 %     12.2 %

 

- 19 -


TENET HEALTHCARE CORPORATION

SELECTED STATISTICS – CONTINUING TOTAL HOSPITALS

Fiscal 2007 by Calendar Quarter

(Unaudited)

 

(Dollars in millions except per patient day,

per admission and per visit amounts)

   Three Months Ended     Year Ended
12/31/07
 
   3/31/07     6/30/07     9/30/07     12/31/07    

Net inpatient revenues

   $ 1,390     $ 1,341     $ 1,364     $ 1,397     $ 5,492  

Net outpatient revenues

   $ 580     $ 593     $ 604     $ 608     $ 2,385  

Number of general hospitals (at end of period)

     48       49       49       49       49  

Licensed beds (at end of period)

     13,424       13,458       13,465       13,495       13,495  

Average licensed beds

     13,417       13,441       13,465       13,495       13,455  

Utilization of licensed beds

     56.9 %     52.1 %     51.1 %     52.0 %     53.0 %

Patient days

     687,564       636,980       633,232       644,959       2,602,735  

Adjusted patient days

     960,155       912,511       910,737       921,434       3,704,837  

Net inpatient revenue per patient day

   $ 2,022     $ 2,105     $ 2,154     $ 2,166     $ 2,110  

Admissions

     135,481       127,560       127,767       130,927       521,735  

Adjusted patient admissions

     190,260       183,960       185,170       188,530       747,920  

Net inpatient revenue per admission

   $ 10,260     $ 10,513     $ 10,676     $ 10,670     $ 10,526  

Average length of stay (days)

     5.1       5.0       5.0       4.9       5.0  

Surgeries

     88,963       88,792       90,327       89,091       357,173  

Net outpatient revenue per visit

   $ 601     $ 627     $ 639     $ 645     $ 628  

Outpatient visits

     964,700       945,369       943,706       942,849       3,796,624  

Sources of net patient revenue

          

Medicare

     27.5 %     25.2 %     25.3 %     25.4 %     25.9 %

Medicaid

     7.3 %     9.5 %     9.5 %     8.7 %     8.8 %

Managed care governmental

     12.7 %     11.3 %     11.4 %     12.9 %     12.1 %

Managed care commercial

     40.8 %     41.1 %     41.2 %     41.3 %     41.0 %

Indemnity, self-pay and other

     11.7 %     12.9 %     12.6 %     11.7 %     12.2 %

 

- 20 -


TENET HEALTHCARE CORPORATION

Additional Supplemental Non-GAAP Disclosures

(1) Reconciliation of Adjusted EBITDA

Adjusted EBITDA, a non-GAAP term, is defined by the Company as net income (loss) before (1) cumulative effect of changes in accounting principle, net of tax, (2) income (loss) from discontinued operations, net of tax, (3) income tax (expense) benefit, (4) net gain (loss) on sales of investments, (5) minority interests, (6) investment earnings, (7) interest expense, (8) litigation and investigation (costs) benefit, net of insurance recoveries, (9) hurricane insurance recoveries, net of costs, (10) impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries, (11) amortization, and (12) depreciation. The Company’s adjusted EBITDA may not be comparable to EBITDA reported by other companies.

The Company provides this information as a supplement to GAAP information to assist itself and investors in understanding the impact of various items on its financial statements, some of which are recurring or involve cash payments. The Company uses this information in its analysis of the performance of its business excluding items that it does not consider as relevant in the performance of its hospitals in continuing operations. Adjusted EBITDA is not a measure of liquidity, but is a measure of operating performance that management uses in its business as an alternative to net income (loss). Because Adjusted EBITDA excludes many items that are included in our financial statements, it does not provide a complete measure of our operating performance. Accordingly, investors are encouraged to use GAAP measures when evaluating the Company’s financial performance.

The reconciliation of net income (loss), the most comparable GAAP term, to adjusted EBITDA, is set forth in the first table below for the three and twelve months ended December 31, 2008 and 2007.

(2) Adjusted Free Cash Flow

Adjusted Free Cash Flow, a non-GAAP term, is defined by the Company as cash flow provided by (used in) operating activities less capital expenditures in continuing operations, new and replacement hospital construction expenditures, income tax refunds (payments) — net, payments against reserves for restructuring charges and litigation costs and settlements, and net cash provided by (used in) operating activities from discontinued operations. The Company believes the use of Adjusted Free Cash Flow is meaningful as the use of this financial measure provides the Company and the users of its financial statements with supplemental information about the impact on the Company’s cash flows from the items specified above. The Company provides this information as a supplement to GAAP information to assist itself and investors in understanding the impact of various items on its cash flows, some of which are recurring. The Company uses this information in its analysis of its cash flows excluding items that it does not consider relevant to the liquidity of its hospitals in continuing operations going forward. Adjusted Free Cash Flow is a measure of liquidity that management uses in its business as an alternative to net cash provided by (used in) operating activities. Because Adjusted Free Cash Flow excludes many items that are included in our financial statements, it does not provide a complete measure of our liquidity. Accordingly, investors are encouraged to use GAAP measures when evaluating the Company’s financial performance or liquidity. The reconciliation of net cash provided by (used in) operating activities, the most comparable GAAP term, to Adjusted Free Cash Flow is set forth in the second table below for the three and twelve months ended December 31, 2008 and 2007.

 

- 21 -


TENET HEALTHCARE CORPORATION

Additional Supplemental Non-GAAP Disclosures

Table #1 - Reconciliation of Adjusted EBITDA

(Unaudited)

 

 

 

 

      Three Months Ended
December 31,
    Year Ended
December 31,
 
(Dollars in millions)    2008     2007     2008     2007  

Net income (loss)

   $ (33 )   $ (75 )   $ 25     $ (89 )

Less: Income (loss) from discontinued operations, net of tax

     (23 )     3       (37 )     (36 )
                                

Income (loss) from continuing operations

     (10 )     (78 )     62       (53 )

Income tax (expense) benefit

     6       (20 )     25       63  

Net gains (losses) on sales of investments

     (1 )     —         139       —    

Minority interests

     (3 )     (2 )     (6 )     (4 )

Investment earnings

     1       11       22       47  

Interest expense

     (106 )     (104 )     (418 )     (419 )
                                

Operating income

     93       37       300       260  

Litigation and investigation (costs) benefit, net of insurance recoveries

     4       (12 )     (41 )     (13 )

Hurricane insurance recoveries, net of costs

     —         3       —         3  

Impairment of long-lived assets and goodwill and restructuring charges, net of insurance recoveries

     (14 )     (25 )     (18 )     (49 )

Amortization

     (11 )     (7 )     (38 )     (30 )

Depreciation

     (85 )     (78 )     (335 )     (308 )
                                

Adjusted EBITDA

   $ 199     $ 156     $ 732     $ 657  

Less: Losses of hospitals without full calendar year of operating results at the beginning of the fourth quarter

     (2 )     (2 )     (20 )     (2 )
                                

Same-hospital adjusted EBITDA

   $ 201     $ 158     $ 752     $ 659  
                                

Net operating revenues

   $ 2,195     $ 2,077     $ 8,663     $ 8,167  

Less: Revenues of hospitals without full calendar year of operating results at the beginning of the fourth quarter

     23       7       56       16  
                                

Same-hospital net operating revenues

   $ 2,172     $ 2,070     $ 8,607     $ 8,151  
                                

Adjusted EBITDA as % of net operating revenues
(Adjusted EBITDA margin)

     9.1 %     7.5 %     8.4 %     8.0 %

Adjusted same-hospital EBITDA as % of same-hospital net operating revenues (Adjusted same-hospital EBITDA margin)

     9.3 %     7.6 %     8.7 %     8.1 %

Additional Supplemental Non-GAAP Disclosures

Table #2 - Reconciliation of Adjusted Free Cash Flow

(Unaudited)

 

 

 

      Three Months Ended
December 31,
    Year Ended
December 31,
 
(Dollars in millions)    2008     2007     2008     2007  

Net cash provided by operating activities

   $ 67     $ 112     $ 208     $ 326  

Less:

        

Income tax (payments) refunds, net

     (1 )     (6 )     (4 )     162  

Payments against reserves for restructuring charges and litigation costs and settlements

     (21 )     (31 )     (100 )     (70 )

Net cash provided by (used in) operating activities from discontinued operations

     (12 )     31       24       80  
                                

Adjusted net cash provided by operating activities – continuing operations

     101       118       288       154  

Purchases of property and equipment – continuing operations

     (120 )     (259 )     (452 )     (622 )

Construction of new and replacement hospitals

     (10 )     (23 )     (75 )     (67 )
                                

Adjusted Free Cash Flow

   $ (29 )   $ (164 )   $ (239 )   $ (535 )
                                

 

- 22 -


TENET HEALTHCARE CORPORATION

Additional Supplemental Non-GAAP Disclosures

Table #3 - Reconciliation of Outlook Adjusted EBITDA to

Outlook Net Income (Loss) for Year Ending December 31, 2009

(Unaudited)

 

(Dollars in millions)    Low     High  

Net income (loss)

   $ (40 )   $ 120  

Less: Income (loss) from discontinued operations, net of tax

     (10 )     10  
                

Income (loss) from continuing operations

     (30 )     110  

Income tax expense

     (15 )     (25 )
                

Income (loss) from continuing operations, before income taxes

     (15 )     135  

Net gains (losses) on sales of investments

     (20 )     20  

Interest expense, net

     (470 )     (450 )
                

Operating income

     475       565  

Litigation and investigation costs

     (25 )     (5 )

Gain on exchange of long-term debt

     170       190  

Impairment of long-lived assets and goodwill, and restructuring charges

     (5 )     —    

Depreciation and amortization

     (400 )     (420 )
                

Adjusted EBITDA

   $ 735     $ 800  
                

Table #4 - Reconciliation of Outlook Adjusted Free Cash Flow

for the Year Ending December 31, 2009

(Unaudited)

 

(Dollars in millions)    Low     High  

Net cash provided by operating activities

   $ 55     $ 180  

Less:

    

Income tax refunds, net

     15       25  

Payments against reserves for restructuring charges and litigation costs and settlements

     (190 )     (170 )

Net cash provided by (used in) operating activities from discontinued operations

     (10 )     10  
                

Adjusted net cash provided by operating activities – continuing operations

     240       315  

Purchases of property and equipment – continuing operations

     (320 )     (360 )

Construction of new and replacement hospitals

     (80 )     (90 )
                

Adjusted Free Cash Flow – continuing operations

   $ (160 )   $ (135 )
                

 

- 23 -

GRAPHIC 3 g7402999_1tenet.jpg GRAPHIC begin 644 g7402999_1tenet.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`/P+&`P$1``(1`0,1`?_$`-0``0`"`@(#`0$````` M```````)"@<(!@L!`@4$`P$!``("`P$```````````````4&!`<"`P@!$``` M!@(!`P(#`P<'"`8+```!`@,$!08`!P@1$@DA$S$4"D$B%5%A,B,6%QAQ=;4V M=K8X@;%"DB0TM-7A8C-T6'B1P7)#DT76MQDY61$``0,#`04$!P$,!0H%!0`` M`0`"`Q$$!2$Q05$2!F%Q(A.!D:&Q,A0'%BPG-TDJ+2 M0R14)546-O%38[,FH\/35@C_V@`,`P$``A$#$0`_`+_&$3")A$PB81,(F$3" M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(HF.2=]\ELO5NL%QEU(Z^`$E895W*+E3-1IXWMH"Y4.FV0'H'0B12$#H'0,L/4 M-M!:X&:.W8UC*LT`I^.U1N.EDER#'2.+G:[>XJRQFK%;4PB81,(F$3")A$PB M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3" M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81, M(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB818_MM]X7"7]D[[)]RK3^-K_`!>:I_FN\?W#GLVGU3_)9N]G MZ;54<3^^L[C[BK1&:E5Q3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3 M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(O03=#"'3X!U MZ]?_`%=,ZQ+&9/*K^L7&K@:D>#C_`$+QW^H``=1'K]O_`$?#.;JM%:57*AVC MX>*QKL?=6HM.Q9IK;6S]?:QBBD,H#^_7&OU-LH"9-2;?L@5]2CZ$[A_-G M?86>0R3^2UMY7G^JTGW!8]S>6=FWFNI8XV]I`4?5Q\W7BGHSI9E-\VM..G2` MF*JE6'D[@D(XJ<',M3F`0'X*?9EE@Z$ZQG>&MQ\P:=Y%/>H&7K'IJ. MO^U1N(X&JQLW^H.\0J[DK;^,*MH"8X)^^ZHFU&[4HB/0!.Y4I`)$)^<1Z9*. M^F'6K6>8+)Y'802NAG6_3KW.3=3M%AK;F=Q^G)%!K022(W$`#:2178L M^'JGIV=S8VW<0E<:`$TU.S:M[HV:BYEBWE(:182\:[3*LTD(QZWD&+I`WJ59 MN\9G7;+$,'P$IA`?RY6Y(I(7^7*US7_U@1[U,,N(916%S7C^J0?YWVW[S']MOO"X2_LG?9/N5:?QM?XO-4_S7>/[ASV;3 MZI_DLW>S]-JJ.)_?6=Q]Q5HC-2JXIA$PB81,(F$3")A$PB81,(F$3")A$PB8 M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$6LW M+#EEHOA;IZR[TY!7AG2J-74@2+W"5S.667735.PK-2A2"5[/V22,D)4&R/K\ M3G,5,AC!*X3"Y'J*^_AN,B=)-0$D`GE!WN(!H/N"P;(UI.A:"30;=10[.&G8MQ>+/TQ>Z-[G8[A\FW)"]DLLV*,N[UA4 MK.K?MAI_,F!=9M<=K7(T[&1\@J4X@=O&-'141$0*XZ^A8+.?6?'8\?PGI"SM MVEF@D<-".P"A])H-XJIC%?36]OV_.=374Q:[7D!(/IVC8=A!/%3P:F\"7BBU M(P:MF7$RIWU^@0I5)K;DS8]B2C@_3[RJR<_*K1!5#G]>B35(@?`I2AT#-87G MU$ZONG.?)>R,!VA@``KK3>0/2KU!T/T[9L`AM&2`#:X[>T]O%;7Q?C?\?<.B M#:/X4<7FZ::8)@'[E-?.C@F`"4`.JX@EE1^`AU,81R#FZJZBN9&N-WWB\ MMI7@#MJLR+IK!7`(EL[>K=E*';W=RX7]%Y7VL4Z15*(_=,0Y3%'U`0')&'KGJJV%&Y"<4VCF#O6"#[5\/2N$ M<2SY*,-.A+30@'0D4V&BUZ;^%;0.JG"TWPXWARIX2V05/F&Z6F-U6*PZ\.N! MP4`DQJC:![K392.$>@';E2;E,7TZ@&=USUYD+R,19R.VN8*U!D:`X]Q%/105 M70SI*RLM<1)+`_B#7V'\*V!U_.\^M%R;&M[V:4KEYKEX!'6.Z8%- M8Y$4WVP-&RLB^J-I8H^X!EG=6E4G10`3!%F*`CD1>.PUR/F;%CK9WL(JX"AH=E6]@W^LJ1,B@&$H]>@"7J'4!*/WO@!@ M$`$!R`/GLF(?R^1NXU]:G6N;R:D5JO[=Q1^`@/\`E#[,[J%N<2X!W(31QW;U\#@=A"\>XGZ_K">@=1^\7T#U]1]?AZ9SY7;:& MB^!S2>4$H=/R]?3/J^T.S>J=WE@\Q_F*X['NK M/7O!"6XG:8A9]>N,N2UWAF^\SRJ2L@K&0LTQFH(R^IJ,%E'VU&C:51DERG5( MD(@KU)F[>CNB.B,GY;KG(MO+YS>8P,/E4TJ00?UC^7>6EHVG8J)F\]G;7F$5 ML8+<&GF$<_<:CPBO;5:)>!?R>7%/EYRKW]Y#>9UL=:]@.*[Z4?3NZ=D2BM39 M3([7U^DP94ZBIKEA`L"S59=%E'P47\XJ0YTT4C`8P#8?J)TG!_!;/&]-6+!< MNNP`(F#F(\M]2Y^VFPESW4WDJ.Z:R\IOYKC*3N,0AVN=I7F;L;QX!HKP"GGL M'*SRL^1]HLV\=.I8?A#QFE"JIQ_,CE]`.$]K;$BU"'(6:TMH`\?+/(6$?HJ` MHRDYUL8'1.TZ1VIP$`UW%A^C^EW5ZFF=?Y4;;:V/ZMAX2S5`)&PM8=#M#@K- M)=YG*"F+8+>U/^MD'B.W5K==-A!-00=H*@S\C7B1\Q_&:A6KELQ\A>Y>5["@ M,%;7L5>K;,W/K[95.@8Y,71^QG_!SEU=G>S;JXJ))!)+]J91I!G/*QDHN'SRC9H[2=*+"5`X0/U.Z%L,7:CJ#" MQB*#G#9HQ\+>;1KV#\4$^%S1I4M(`U4ATKG[B[E_AU\[GDY26..TTVM/'34' M;H:UT5Q/-)*]K0'R.^1?1?C1X_2&[]R.%YB6DG*\!JW5\*[;-[9M*Z%:'>$A M(@[@JJ47$1S8OS,M*K$,VC&8=Y@46.@W6L?2_3&0ZJR0Q]B`U@%9)#\,;>)X MD[&M&KCP%2(S*Y6VQ%J;B?5QT:T;7'@.`XG0;DQ MNGCEK_:T6A9]6<)^(5ODM#,*EKZ9`CZMO=S;3AT?WL7"T3L4HFZ/'ED6*3-- M1/W"D5,HT;V;+93I[I>Z=BNF[6"ZN(3RR75RT2ESQHX11G]6UH.G-0DZTTHX MQEG:Y'*PB[R4Z?N8HC=L[!7DYR0X#@=O-WUKL6`/!!Y^=I[YVQ7>%/.>>8V6[W4BT?HO>KB-CZW. MV&TQS51P;5^SH^/;QT.YL$LR:*FB)1%NU7/66*I<`TG]I&34T!(YFDD`>($`$+%Z;ZFFN9AC\B:R.^!]*$G\EW:= MQXZ'53*^0_A9Y%]P3%LVMP>\D&PM!SZ=8C4:]QXE*=17FJ)B7@V"A%P:W9:% M>VNK2=I6`!4<.$I-JFN(?JTT^HA1NF<[TQ9,99Y_%QW,7,:S!SQ(`3^34-<& M\`6FG:K!E;'*3@RXZY=%(!HV@H=-E=:=]#J==*4HOJ^7'S*Q>V@TI;^;6W:% M?6>S$-36:/MT?KV/3I=N_:Q*FRR-F,2C*F:M:]+F.+LY`.`))&,3N#IU]`_] M&=#/LOGX+""2W,7F-+2\\S>7F'+X]XV+6_\`',\)OEWW#VR<_*:\NAK0U\.X M[5V$O"'B7R=XXK3\QR0Y_;>YER]DKCT"DTNGS+-TH\D9BI,JQ'C/J M*O@5^7'YY\N`HI@/84XCT\UY_,XG)\K,7CH;%C7$U:][G.&P!Q<:=N@VK:5A M9W=J/]JN'3O(W@`5[A]W'=3&O-SA)S8WS<9?8'%OR:[>XH+#4XR)A]3L=<:] MN>JU)^**^,>9>O7[!O`SV!QT+;?+XJ&\' M.29"][9*&F@`\)INV=ZZLC8W]R2ZRNG0.IH.4$>_[U=>ZE%SD_Y*_.'P^WML M7CIO/F1MRO;(UI+%CY9!HUU\\AYF->-DI&`M59D%*"W-*UBT0[A)XQ7%-,YD ME.Q0B:Q%$R>@L3TKT!F\?%D\?8P.M9145+P01H6N'/HYIT(]510K6]YE^HK& MY?:W,[Q*PZ_#0\"/#J"-0KB'B*T-SCM>L..',ODWY*MN[VCMJ:O9[&'CVWJ. MMF&K$HW8U24<5QA.VAG7DK9.3=62E4'2BC8\>@620%+L42()E-(]:9'I^&\N ML'B<7#;NAE+/.YGF2K'>(AI/*`ZA&M?":Z'9?,';Y!]O%?7ET^3G;SW0[E M/3QNEB,;'%CCO&T:_<%33\S#KRS^+B-TS>:'Y5=X[MHFYKA)Z]CX.P4/6$%L M2$N#2)/-Q[=LC`55]'VV,F6:"B13H-F:Z#L$TA35]XI@WCT,WHWJUT]OW M@N(&!Y(?(6%M:':X%I':2"*FHHJ%U`[-8@1RQ7DCXI'=O@YY,,QG4^-QXM)7!HD9"UH83H.9IYO#N+@06[=0N>2Z=O+:%UUBK MJY\Y@J6N>3S`;:$4U["#52M>#WDAN;DKXL])[NW':YS<6VGG[WHZ2GYDD/&3 MUL4IFR[I`5UB\<,F4;'"]/%135H+I5(IU#%]Q83'$YAJ'7^+L<5U=/86+&P6 M8\L@"I#>9C2XBI)I4DT]2F>G;NXN\-'<7#C)/XJDTJ:.('LH*^M8&Y'<_N8L M5).:RMKM?CB@M[B:!'T"XE[,Y1-_I-K3.,QKSGH7X*Q[7T^)5!^.2&+Z3OVGDY?*]%3ZSIZ@LA>/SD;*UW7W*?;&Z[[;;7' M5$-?R)3V*>DYUZL_D$K>BWAX%O(NETD)*Q216[=)%`J95%1)U#M+U#&ZDQ;) M;FSL["-C'/YQX0`*#EU--S14ZKMQEVYL4T]PYS@WEVDGCH.]:V[FW5Y"2RZN MX;(ENG5%1DG)7T#&P[&3BZ37XM0WN1C"08I(*ME3`V[?<5ETO<;L6)/<93F\]_F,C.S<`-WW%2.>.OD?OOD0R MOCS9Z]9EZI4"Q,5&V1C!_@\Y*65\!W;EHN9@Y)!KMH^*3(=;VVJ2GN.4O7IU M`:QU-B\=C'1MM`]LSZDM)J`T;]==3LU.PJ5Q5W=70<9J%C:"M*$GW;/>LB7/FBX)A>^05U7:,FK5^H<:W1DI)(RR$G9!;J$56=)L"F>?+=Z9$6 MB8KKF`@D(KC8K"LN+=V2R#C'C8P34?$^FYOITKQT'9VW=\8Y!:VP#KIWJ'?[ M^[4K[S'B`\M48FZWGO?=>Q;<[3]Z24KM\E];4N-=JE`RB%9J5,4B6K9FV4$2 MIGU:[EF[!['6V?4-#?+2K1G";)IRC1E=(1D?['V;^A7N1-M^\Q_;;[PLR7]D[[)]RK3^-K_ M`!>:I_FN\?W#GLVGU3_)9N]GZ;54<3^^L[C[BK1&:E5Q6J_*OE73^+].;24D MU/9;S8S+,Z-1F2WMO9MXE[9%7KU0A%E&,&P463!98"'444.1)(ICF^[+X?$3 MY:6W;J]YV`LZ+"O;V.SCJ=9#L''^A8UH^@]R[B@FMPY/[.5<9&Q MLI#!B88W,::>9(`]SCQ`/A:.%!VZ+JCMKB=OF7DC@3^*T\H'8::D^E:X\F.( MNT]-5>4V[QDW9NINI5&JLO9*-+;!L4^JM#,RF6?R5?YU=1]/,L&?.V0/RU:.:=>4G80=O*=FNH/&NG/& M9)UP?(GIYM-#Q_I4H,[.P]8A96Q6&29PT%",'4I+RL@L1NRCX]DB==T[ M]8+Y$<0]_P"A:[*;DT;R.W-:BUANO,6N%L%KE5[$G%-BBM(33%=LY"*GFS%$ M#JN6;AF!O8*8Q3*=/;&0QF:QV0E%CD+6!G.:-+6CEKN!WBNP$';P6/=6-U;- M-Q;2R.Y=2"36G'@>T469^`O.:9WN]W M4'>:KOQF1=:!4'B/PJ22XVR#H=4L=ULSP&%?JL+(S\R[$.X48^+:JN MW)DT^H"JL9-(03('JV)AD?HUHJ5%%I MVP;V\@TY=+?([.MNB]`5B;_9^&J&LGJ<1;+$\,W0?';S%K*F=T*C2.<(*.S@ M!D/>7!-!$H%.IEPOH\?TW''`V%EQDGMYBZ05:T;-&]IK3?I4G7 MNCM@:`-T)[S[_&J+):8L=4L-[EY.46A69#+24 MI#2#0[)N]4C6Q3++,W+93W4"'[#]P`F?GB\W97\[;/)VUN.W89[663PZD$G9Q'X"I!^(UULFQ>-FH;K;Y92=LL_5$W,Q,+) MMDEI%VB_>LQ36FS7='P"YO MV^=*YT=N?A:W0D<2[;ZE^?!2?&GE+K:21LHXN)!^^%JKP\Y_;)A-C,-)\DI%S+,Y*;-46-MGD$6=HJ%M M(]/&I0]K<)IH)R<:XDR_*G<+!\RU7,4QU#I=W9,9OIRUDM3?XL`.#>8M'PN; M2M6\#36@T(W`K"L,G*V46]V:@FE3M!V4/IT4Z>:^5C3")A$PB81,(F$3")A$ MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$45/D*\1G'KR6V>@SO(?8&]6D5K M2*?1]3I%`O$;7*8SD)5S[TG9UXES7911S9WJ!$VQG1E>I6J14RE*'<)K?TOU MMENDFS-QD41=*!5Y'B.W8:BE.Y5W.=-VN?;Y=U(\-`V"E/40OFOM9A;M.\43(9POV@0 M5/;^YG9U3]0>HNJK:&'*24@C?'E+!6.R<;.,6L=VP]2D$8>QOZ'I2=E6L+,/& M!I!E'2!QV.U,FY<-.BA0`1#M^W)3*_3CZ:=/O%MG;Z>*Z>QQ9X@`:;-K#M6# MA^M.MLY-S6<##;@ZT:-%*7S]\]=SX*:?XYZR=ZAAKQY`-H:8H5ZVSKV73DH6 MH:8L%HA&HK,+#`Q3M]87D_)6`[A-C#(+@8$D>XZWWTRJ43I'Z;-ZFEER=S(8 M>G(I2UL@(YG`$U-378`*Z5JK5G^M;S"QV]K%"QV2G:[F'`M(`%`=IK7@H^+5 MYKO/%Q;A:SO7E?PFI[#0=@>Q@#^,:NLE$;D0E_;68L5+0PMD^]JLF]1.!6HR MS,"BJ8`,4Q@$@VV/Z9_3W)W4MCTWDO.R+12A:UTTKK7AHIV+SY6H?9GB)V_Y&N)Z<5^T]$UZ_E4Z;L! MBI)DI>R(66B(JQ4JWQT<]BUG1XHTB84U4U$2NFZB*Y.A3@`:U9T<^VZXBZ2Z M@861/=\8WBAH1MX"O`J]MZJAEZ6ESFHIZ#715U=.?4K^3+<-;LVOM M:\7*%NCD#(RK"3K#G6VL[Y.1-/H;5DLE-.I:EP4[+2DW,O)&^LF%OJ-:L&O+3KG84B]&. MB8:]TV>E),AXQW+"1F^I5]=7[<5FK<13O=MI0UW:>FO=PU4KGF+\U=,\8[6K:UIE M*C=O&2.;W"% M+U&B=!_3V\ZTD?<2O\G%1'5YW]@)TTW[>"M_5W6,'3/EL#/.O'[&CA[_`,%% M"K8_-9Y[-$5&'Y'[\X1TV.XYS"L8[4>3FI+A3X=O$RIB?(?.V1M<):>JR]4F7K3K:S MA;?7UDUEBX@U#3J#LW^@Z]RD^VMY9^5?)[@;I3E%XFM&FVKM*=VNO0-[ZCG: MFKL*8U(,75GTA*LI)K%3E<$$_P`9,Q%F_P"X$W;5P4X$`>X`HT'1.+PW5+\7 MUEWPB05V@D$:;%;+GJF^OL%'?\`3L0DO.8!XI4M-*^U0C;'^H,\ MU>H-L--$;1TGI.B;D?.ZXR9ZUL6GIUG:E7=O.BE5T08_O!41*I.*N4RM_P!8 M(&$X?#-HV7TG^G=UCQD[2_G=8\U20X;-:[&*C77U'ZJM[VP'N^S-4]:8?H/%XSFZ7NG3W9=0^($>H`*\]+Y'JW(W! M.>A;';C904[NU6"N[]3U[PZ]O;W]/]/KV_H]>G7O].GYH`#A;D'_`,HJF']+WH#2N^.?>P5MS:TJFS2Z MDT$^V5KME?U9R5]C^G(Q8ROB\ZY#'EIH7,Y'DMKM`)`K0BNPZ5"H/1UM!<9-_GM#^2+F M%=@/,W6FP]E>_:NQ^SR^MK+\$K%QTY&2,++LF\C$R[!Y%RD>[2*NT?QT@W4: M/63I$X"19NZ;*F(KU864;-JOS8E=3M12.)!-6WMIMVL738P^@F25@'IRF`?T@SU[U72^ MZ$NY9=2^P$GYP:U_O"TQB/U&?A:S8+CE]%2WW+M8L\@+="ZV+RJ\H[)SI\V4 M94&VM[SR)U7QOW/"Z2U]QYURH1Q8MFP^J;"E.[JC*PD+9VS_`!G8]EKTFBN[ M.BKTB63*U M/F;MV2ZA$?(Z6&*0,:P;7!IJ^GVB#K38!P5H(GF:YM)$(DEX'.?R::9"D33( M:*(0A"`!2$(0M1`I2%*'0`#T`,U+_P!#X$ZGJ''5]/\`I*Y_QR__`.7W'M_T M5[__`)G>;W_\'_(#_P#$C/\`Z2Q_T-@/_P!AQWM_TD_CM_\`\ON/;_HJG=OK M@?Y);ERXV;R:T#XX>86CV5CWA([QUC6PUI+/I;6-@>65*[,DFN[<=U%TM!A8L5DLI97#FVXBD=S@"0!O(:@DG5NA[50; MK&Y9]\^[M;6>,&0O:.4^$UKPW'8NR?XC[,VGN/C-I'9V\-6S6E-P7'7T%*;+ MU;8&KAC*TZY@@+6?CUF3M)!VR07D&QW#=%4ONI-UB%.(F`1'RWFK2SL5U/BA9Z[Y;1"J=K48I>PVB=Z4./9,)XYS(]`;+7>G`PDDS#T.N]9 MR"GJ(".>A?I'G_XAA'X>=U;JR=X:[XGDD?Y#JM[`6A:WZRQWR]\+U@_53C7L M>-OK%#W@JV9X/N<7\=GC[U/=[%+$D=O:L0#26ZRJ*E,^7NU$8,&["T.R&4.L M/[>5%S'3!E!`I#.7:Z9>OM&Z:;Z^P'_3W4DUO$VEE-^MBXA]2HXD>3W,;<%[TWKQK+4#Q[ MZRTOI_DSMN)`IE2WW=MKGIFGUR443'M?-:>=^1B(@`J,G;QR18W9[92^E?I8 M&XG"0V]]*6W.2EED@C/Y$30'.'#FI7M`%-ZU?U;6[OGRP,K%;,8V1W:\F@[A ML[#6JFA^E@YF!N?AK;>*-IE`7O7$ZS`G6$7"Q/FGVE=CNY*=JID2&'WUTZM: MD9>,,/J5!J#(GIW%`:+]7<'\CG&9B$?[/>,\79*R@=_E-Y7=IYE/]&W_`,Q8 M.LGG]9`=/L.U'J-1W45H[-2*XJL;M4B7DJ\_&L]1%*2>XW^)6C!MC8!!`KJ# MFN3][4C'=6A5Q]E1NL\KCEM%+`BIU$BU>D$_3N'-KV?_`,6^G,M[\.4S,GEL MXB!E>8]SO%K_`%VE5";_`(MU,R#;:6+>9W`R.V#T:?Y)4R?DMU_>-J^/GF?K MK6J#QY>[?QKV]#5B.CBJ'D)>4<4R6%.$8)H@*JKV<(0S1(A?4YU@*'QRC]*W M-O9]26-U=4%NRZC+B=@',-3V#;Z%/9>*2?%W$4/[5T+@.TT.GIV*@?X#O+35 M/&QN:\TW=K&1/QKY#'JY+K8HF/%;HJR$O6E8Z7693;1N M0SU))-!RB14S8Z"WHSZB]&S=4V,<]@1_%;;FY&DT$C74)978'5%6$Z'4&E01 MK3IG-LQ,[H[@'Y26E2-K2-AIO&M"-NP[J+LE];[+UYN.CUS96JKK6-B:_M\: MC+5JX4^98S]>FH]7+JTN;&X=:WD M;XKEAHYK@00>T%;8AFBN(Q-`X/B<*@@U!6,>+_%[4?#[4[?2FCXJ5@]>LK;? M+FPB)::>SJK"5V-;YB[V)NR=OS&6;Q03LXX%JV+^K;(B5,GW2AF5ELM>YJ\- M_?D.N2QC20*5#&AK:]M`*G>NNUM8;.$06XI$"33O-3]WWU@'R=%*/$>VB8I3 M"2U4`Q!,4!$AAM<<03$$0$2&$AA#J'0>@B'P$%';XOM1I[-N=NF+&^!U1-:S%-MQJ:<`,TL&Q0;V5K2YJ63$G:Z94]F+]=! M(P]OSRR2G0?;];-U9>FT@8R(4N)6N;S;PSP\P':XT![`1O47AX/.DQN"A`^Z``&Q\[:6SK"+'_,16T`(IS?C!HH`-FPFI[:*LX^:47#[GRWRO M(W;B=_WE*A_&AO#_`,!O(+_6:?\`*E3/S]Q_NTJQGN7D-M_ M<6J[YK&4X([^;MKG6Y&'2>JD;+DC9)5+W8>5%$L64ZHQ4LD@Y`I1`PBEZ"`^ MN9=CC+*RO([MF0MB8W@TXC>-N\5"ZI[J>>%T)MI:.%/P>HK1OAKKCE9H??M, MM!M%[-;UN>=MZ7>0?5N191W[+3[UHBZDW:YB"1$*Z\32D"G-Z`# M?['V;^A7N:VMOWF/[;?>%:)?V3OLGW*M/XVO\7FJ?YKO']PY[-I]4_R6;O9^ MFU5'$_OK.X^XJT0(@`=1]`#U$1^`!FI5<565G]PS>\>="6RT*)9]P151N#A: MF:YK!2+23ZIZ]5=G@?E$5DG+=-H>51)+/.I!`YE3A]H=-JQV4>/Z?^5,C('O M9XGNV!S]OIIX0JBZ=UQD?.Y3(&NT:.#=GMU*E<_C0WA_X#>07^LT_P"4Y3_X M%8?\QMON]*FOG[C_`':5>BG,S=BR9TE>!._U4E2&3534^3.FHFC;0:;+UUQXVY`JURZJVR MH1SJK/W)XUFC++/8Z#?*H))INT`C5`9N.T`*JD8P=``W3+P_(8BXM#:W5U`[ MFCY7'F&II0D<-=0H!MM>QS>;%$\$.J-.W9]Y3\;WT_8N5.CZI374_*:B2M+J MFV>_Q@L/Q*82BTHX\K(4I5)1=BB5ZUG56X'.J4R8':CW)&_0'7..O8L1?OG# M1,6!S6&M!6M`[?H179QVJS7,#[RW;&265H7<:;QZ_%W2_LG?9/N59_P`;JAT^7FI0(82^ MY'W=(_3_`$DQH%A,)!_,)B`/^3-J=4?R6;O;^F%4<3^_1]Q]Q4\7-ZOS=GXH M[MB*ZW7=RAJC^(%:M2F.XJLU6$.W?/5I!TBV5>.7QB*O'`BLN(+N MC]!,/4"]`^S.R[NIKVX==3D&9YJ:"FZFQ<88F01B*/X&[%`MY*]IRVU.1T-I MB(3D9:`UT>%A$:_#"*KR=O%M(Q=2H,T2@(*RQ8Y\UCFH"!A36]WI_P!H;KL3 MI:S99XMU\^C9):FIV!C:TKV5!3M].Y2!PW+C;]> MAXJ`A^`>_F43!QK&(BV:0LRI-(Z-;),V39,H1/0"(-D2E#\P96WX6RE>9'Y& MV+W$DGM.IWJ4;?3M:&MMI0T"B^G_`!H;P_\``;R"_P!9I_RG.'\"L/\`F-M] MWI7WY^X_W:51+\BM-;^W-N.X[0JW%G<=*97!>/DW,(ZK[EZY;S:4HY<\9?8ZQL66DUY!(Y@(KS4TJ2!3L&G48;5Z"0I2@`!Z=P?$1 M'[?RB(CG/XC5VJ^2/=4._&K38%$[YRR@'B:YOCZB/[I$OB(F^%KK8A\1$/B& M6_Z=1,'6EB\5YG2ZZG@>U5KK`\_35V';!'I[%#G](P!?X])`1`> M@]I=?D^(_;]X?CFS_P#^@`'Y^Q+1J('^QU/2F^; MA:^=W=UPH-/#:&VJ7R>HX:JUY+0SNU,[/*TV`JHT:OA7FR[5Q*-5_82.1NF< M@F-Z]W7XWSHO&6+OIS#:7,Q@MI(RYQ!.UXJX]G'L5"ZJN[IO7#Y+9A>Z-U6M M)WDU/M&ST4U4AO)+G5]0+RET3L_CWM+QPR*E#VS59"IV$T7QEV6VE&S=TH10 MC^)=R%H?LVDM'.VY54%3HG]I8I5`ZB`94\%TQ]+L#F(LE_%K@W4/"]YH:%R$T MKM33D+*5+75OH[/9-6E*RG,2+@1A[8ZA4Y%-,KDXDC8X'(D`.TQ2@/7XYE=2 M76+R_P!2<3\#3YHWN"F`]HG]> MG7(/Z^N?\]86H)$)9*:`D:AU`?5IW5XE2GT@C9\O<2:.?H*]E37W>Q1;^21J MT;_4A-4$&Z#=)SRBXB.E4T4B))JO7+?62J[I4J92@=PNH'<I(@?J3`UH%#*TGV5*QCYN;;L5SYP]JR M4)61OEVI5YX_,=;45]'+33.QJPE3IH MY-?3YML_Z7.M6-,;)"?,<"034"IYJU&_91=76ES=GK:K:!\;1Y9(!&G810@= MM5(!NWR+_4";YU)LC2FP_&P^>4?:%.GJ/9D&?&#:'S:43/QZT>LX9'>69RV2 M?,?=!5`YDS@FJF4P!Z!E6M.DOISA[^+(VF3D=\88XW2!S6T[*;QWZ*+7S7=P?4%4X2C]T+O MPF-^7H(O*H;NZC\!$?7+S],N4_2D\X!)BG.H_)=IZJE5#KV.'_KR!M".8-)H M2-3RZZ+L30(4/0`'H0`$H=1Z`(]0$>G7U'H/QSRI)M!XNU7H"&-C86L:/#K] MU=J_MVAV=O3T_)_ESE7Q57RIY*[U&5YH/_U4<\O_`"YWK_ADG(?_`,I4E_\`=_6>;G^LW_;MM_C!_P"W(J/T1_,Y M?[@_I-78/9YM6T$PBZI_@>565\WO'U4H%34<>1=_)'*4#G*4$-OV>26(7IU- MV@FB8`$?A\1].N>P.HJ,Z!N1PQ8'_P!-H6E\;XNH8O\`%U_SB5VL&>/UNA=7 MGX@+:UK_`)U=%35\.!7TSR8Y`0#Q1X8.X+IHXW2;3,\>DAP]Y7:& M9Y+6X4PB81,(HQ/,'PE2Y[\!]TZ6BH])YLR%BR[2TFL8G@(.Y6OQSK?2J5OTS_-U;B]SO\`W`7607B-9WU4P`R_3W\1@`==V1+P M1OB=3S`.P>%_ET]04<@/V9YRP>*FS>7 MM\5!^TGE#:\&[7._-:"[T+9M]=LL;22[D^%C2>\[AZ30*)_QK>.I"U^*;95& MY2-#R6X_)=&;%W]R9FY%J52<:6W?C526J`?K3`NE(ZZA%HQVV0.8/DY8BW:! M?7+CU3U.8>L(KC$&EEBBR&`#9RPZ.]#SS`G>VBA<5BQ)AGQWFLUV'/>=]7[. MX@4--SJJG#XI][73Q5^6VO5#<#@]9BV>R;/Q$Y'-EE3-HU&(G;*C6FEH<>@D M-$UZ\QL1.I+=!`8TJABCVJ"([OZPQ\'5_1CI[(<[S$VY@.^H;S%O>YA#%9 M04OQR<;-OE:K643EZ&*ZM%H=,XY'I_[UR7/+V$Q_NV6%G)=R?#&PGO.X>DT"BT^GQXVVW5O"A]R6W$5=UR&Y]["G^5>U M9B035)*JQEV>/'>NXUR*_P"L^5&OO5)A(@_]DI.*D^STMWU)RD%WGABK&@QF M.B%O&!LJP#G/K'+V\@4-TQ:/AQ_S<_[U.HRX.I8=&N/$?DD^HGAM54OBOS?Y_>&OD!9:7#)VK7TC7["BEN7B MSMQK(A0K68IBF,N^@!5,2&E))D'?'V:"4*HNB8BA5G;412/N#+X#ISKC&LGD MY)6N;^JN(R.=O<=X!^)C]G!IU5+L\CD\#!X9&'8X<#NZ9I_&X*\7?H.4?E*_( MOIV>\+2SP]23$&F^X85"!)F>Z_E02'I[BD?\K:&7N`'Z0D1/3X2H_!.%)&_C5!]ZFLRB*P)A$PBX?L/\`J!>?['V;^A7N=]M^ M\Q_;;[PN$O[)WV3[E6G\;7^+S5/\UWC^X<]FT^J?Y+-WL_3:JCB?WUGZ`=,U5``9V!WP\X]ZMTE1&Z MFVA]RK?^+^2:,N5]92?&*#B7HUUCF!E!`!-(?AS24,4HF]?=.RC5_P`X^N;0 MZL:78=Y;L;(TGNK3WD*J8<@7HKM+3^'[RLRYJI6Y,(F$3"+&^P-PZKU4T%[L M?851I:/M^Z0E@G&#!VNF'^DTCU5OGWG\B29QS*MK&\O'O4^@*&?QQ=O\7^H^T1$OREW[1'T$2_N_L?01#[!Z9>.J M/Y+-WM_3:H#%?OT?->(*@;W$!Y,MKH[>W=Z.'=L[E'%HSDW MO3B#<'M>13DR0\;*J-KGJ&XD=M&)7)3@#T&K=P0SFK3HE^\1TW+[:H]IE4UT MQ`,L^0Q6/S4`D-.ZF M5YG[!-_:5H3-3*X)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8 M1,(F$3")A$PB81,(O4_P#_V@_P`^*TUVKA)L'>%%=YM(6C'LU,2"_[4UTXHL8R.1UNE6FZPY?-B40J9G+)M.,F"KQ!)8G:8Y`,0#>@CUS87UPR5E?YFT?8S,D M#89`2TU`+G`C7N/O51^E>-NK'&3VUZPM)>TBNPTJL7^=SQ,\FY'DG`>2K@G" MRMIV'%N*=.[)H].*DI?82Z:Y%K^S&T*9&'%(UE*[CHYNTE(]`1="#8$D@C4@#34<%A=<=+W4F9;G\4"XQCQ! MNVHXC>#M!KH>\+&L#]2!Y*EZDUUZ7QFS\_OA!@G$JSR=1W4WBG\TF!6AI1?7 M;>FB^;.7"X=YFJD35D@92+:2NLZP60<5F1KYU%&J+<14>.&:9%%B%4*;K3[>'I?#?4.PDPU MP9,;"_QN)\-0#L-=:[Z[U.^9G;[H^ZM\NQHO)#5H;MIH==!O&G85B;Z3K7^P M:#J?FN"R#TU M@9Q"T05I&&1,*Z@K`1+L'N$!#+#TI?XEWTKFL+N9C+H03AK"14N=S%NG#CZ% M7^H\9E)^O(KVWA>8&N!YJ:4!%?7N4H7U`_B+WSNO;53\@?"Z&DK1MNHQE=9; M-H-<,D6[/'.OW17E#V306ZXI$F)N#11(W>,2#[ZR39NHD"@D.0:Q]+>M["RL M)^EL^[R[.5Q\M]1RCFVAY-*=FW;37]U%F<6`9&@<[=>8T.T`#73M M'M6OE0^H_P#)#!4ICKBX>-NR6W?;"-1AS6,M5W1`,IJ612!NE+2&O4:4Z=I/ MG*H=ZS=L_(D<_4""0H@`2$OTIZ&D4$#3@/=L*P1]0.JXV"V=C' M>;L#BW7O*GU\16W_`"/[FTU?+AY%]2,=7V:8O;B:U.F9A'U6?7H8DCF\0'* M==H.HKNV"JOG2]QG;F*2YSD7)*2.0#AOKL^ZJJR>934VU[+YYZO;*[JG9MAJ MJ-RX:K'M$#0+;-5LB<6_JBC(AU$I%CQ*)EQ.L4$2E$3B4`'-V=`YC%6 MGTW-A/<1,NHH9N8$[>9U0!QV:K5W6F-R=WUO;7D$$CK;F:*TV4`[=FBOK7'9 M.O-=M6S_`&%>J=0V,@Y,QCWMSL\'6&CYZFG[ZC1FXFGS))RZ(B`G%,@F.!`[ MA#IT'/-4,%Q>R>7:QOD+#4\K2?=5;R=>6MM"U]S(V,&OQ$!<*0Y-\;W2#U=M MR`TFY0C6Q'LBLAM6B+(L&:CUK'$=O54YXQ&C8\@^00!102D%99,@#W'*`Y!L M,@"*P3!QV#D-2.(TV;?4L<9#'EFD\7*-_,*>M:;^:(Y">*?GD8YBD+_#K>"] MQS`4.XZ"!"%ZF$`[CG,``'Q$1Z98.A?^\,=_B6K&Z@_DMS_=%5&OI(S%#GMR M%()B@8_$F4$A1$`,8"[?UEW"4/B8"]P=>GPZYN?ZS?\`;MM_C!_[JE09QS1R^=K'$`(BU:(G<+JF$1``*FDF( MB(_8&,.T6S&>MS&+3>!'G9^!W&5SO8XKM M1\\AK.=D-8M7W\&I?Q)@Y8JG^<P@G9V(RL&6M!/$0)0*/;O:[\!W'>.VJD3R MLJ56J_,'F-I3A%IZ2V_NB:BRL6BM*O>[1D;!\3Y';&M:-23MV" MIT6'?7UOCX#/.>P-&KG'J5FR/J]-5%[8:_#3CNJ65-F MC8JRZEHYL_7K\^E'NY!@E-0RK@6SHJ"ZR)5TS`10Y>AAC9HQ%,^)KFO:UQ`< MVO*ZAIS"H!H=HJ`:;EE,<7L#R"TD`T.T5W'M&]PTEFH!Z M!GJ[Z<9QG4'2[+>ZH^XMAY$H.O,RE&$]CF>$\2TK4/4U@['98RQ>&.4^8TC< MZOB`[G:]Q"GBLG,5CYT'7BCX;UPZ3F`N"#7EWY'H6,.7Y2N17'.2"N?NQF2M M0,+&,V5M9LJJV;J@`BR=Q;@`$I@'->181WT_&8SDNDC/]GLB=KC,.;S!Q+(Z M5/$/"LQOQU%\G8MIRN'F3CAR:JO!.5!$3&'/2/T?SOSF)EP MDQK/:.YF5WQ/.H_-?7T/"UCUIC_)O&7[!^KF%'?;;^%ON*RU+'BV*)&[*-BXQJDRCV#-`@`1!JS:($33( M`="D*`!\,\^O>^1YDD),CB22=I)U)/>MCM:&M#6BC0*!8@Y,;QBN,W'O='(: M=K<]<(/2FM;=LV9K%7%@%BFXFFPSJ_*Y*#&QN:R2>5L8E.D?YF`M\(RGXE4XHG52!46+\G>`&$"GZAU],Z M+RUFL;N6RN!2>*1S'#M:2#[0N<,K)X6SQZQO:'#N(J%$/YP?&)J7GIQ6OU[& M'C*]R4T/0;5>-1;0;-D4)1ZUJ\6^LDGJVV.DR`K,4BVI-%4TTUA,,7(J)O$! M*(+IKW3H#JR\Z=S$=OS%V*N)&LDCW#F(:)&\'M_SFU:=Q$%U%AX,E9.DH!=Q M-+FN[A4M/$'V'4;ZUU?I!K3;?XF>7-68KOOW?36@J):YQGU4_#R7"(OPQE2< MJD#JB206@I^8(4?TCII"'J!/39OUJAA_A5E,ZGS+;E[0=_*65=Z*M:JMT,^3 MYR=@_9&($]X=I["5;;\G9R$XCVPIC`4RMLH!$P'XG.%JCU!*7\H@FF8?Y`S3 M/28_XTS[#_T2KMF/W%WVF^]:L>'?_=>0?_?-9_\`#7?)?K;;;=S_`.RL/!;) M?S?[2FLRB*P+%&]-;I;>T]L?6ASD34N%3EHEBLH/1-O+&;BO"NE!Z#T3:RR" M"AOS%S,Q]U\E>Q76YCP3W;_95=%S%Y\#X?RFD>G=[56EXH;PE>*&_4IBTQ\@ MUAP5D:!M."!$XR+%@60(D]<)M!`#JR58F6)5RIA]Y5,BJ91ZJ`.;4S&/9F,= MR1$%^CXSN)IIKP<#3LT.Y5.RN765SS/'AV.'W<"K2U;LD!<(&*L]6F(^?KTX MS1D(F8BW*;M@_9KE[DUFZZ0F*8/B!@]#$,`E,`&`0#4^HB/H`!G1: M_O,?VV^\+G+^R=]D^Y5J/&U_B\U3_-=X_N'/9M/JG^2S=[/TVJIXG]]9W'W% M6ACD*H0Q#E*@AFI5<%4]V1!V[B#RID_PA([ M>2UQ?26NFG<@8C::JCUVK(0I%#%Z^XQE(%T=@Y$O7M."Q/TBB&;BM9('EVL=4=HW>L:%69='[NHN_J!$W^B22;EH\232 MEHE15/\`%JS,E3*9[!338H@=N]:*"(`;I[:Z?:JF)DS%,.JLA87&-N76UP*. M&P[G#<1V'V;#JK=;W$=S$)8SIO&\'@5E_,)=ZP[N+=U.TO%1#B?"0FK':9=G M7Z30ZT@E(W.ZSCU=-%./K\099$5B-RJ>ZX<*&3;-DBB90Y1$H&SK&PGOGN$= M&Q,:7/>[1K0-Y/N&T[ECSW$=NT%U2\F@:-I/8%K%Y#.1]JT#I^'3H:XQ-VV/ M,K5Z-FSI(K.*W&-(\[^:5X^\ M2`3LK0G=QI16RXF;;PNF<"6MX+(C%ZTD MF3218+I.F+]JW>LW2)@.BY:.DB+MUTCAU`Z2R*@&*(>@@.8KFEKBUPHX&A7: M""*C85'AY#N,%3VMJBS[7CV3>+V;K*NOK`A--TR)'L5:A$#OY:NS8E`/FR)1 MZ2JK)4W51NN4"E$$U%"C9NFG:-X[:*+REFR:`S M@4F8*UX@;0?O+67P]24N")_6-_%\)].JU=\F&I)'77(Z0N[ M5!9O7=L,V=HB9!`#D(A98ELSB[(R*N``4CY%PV;O@Z#U[78"'Z(])?I6\;=8 ML6YUDA/*1_5-2T]VT>A8>7@,5T9!\+Q7TC0_A4P_"SE17^1VLXQ%])M4-K52 M-:1U\KZJI$WKI=LF1LG;8Y`QO<=0T[V@H8Y`$&SDQT3]!`@GI.=Q$N,NR6@_ M)O)+';OLG@1[1JI['WK+N$5/ZYH\0^_W'^A;G9!+/7"-B[&IFJ*A,7J_3S.N MUF$0%9V^>'^\JH(#\NP8-B]7$A)OE`]M!LB4ZRR@@4I1',BUM9[R=MO;-+I7 M'0#WG@!O)T"ZY98X6&24T8%^FA6L]YIE:N!Z]/U0;)$M)G3J`_ESC'*Y\9) MT<$>^,^!VU"@01[^HF[>O03#^CU^(%#\@],ZS)#R^:\UI[^Y`X.%&B@"]#%3 M$W0*!B]"G,`!ZB M)3CU'\O4?B&=CG%@(>/#3;P[5S8'1[6BJ]%"=@=Z8`)NH?>$P]3=>@?'XB/Y M^H?#.N*)A/,'NY>]<9`T^,@.$T];XRE8C7%QU4_(W*4'!9J+)'$4`XD?&)V];%;8&YR[1'@IV27.^ M(T$E1PJ:'0UJ#L4-<9=EA)S9&+DBW/&H_H]JV'R6*F,.3BFCN!MY@>77 M7NKW*0M\G9W[?-L7L>#V[N[;[`LS&0((#U[@`.O3[XE``$.G0!^)0#[`#TS! M:US7%SCX5EZM\3`"]?TZ#V@`"?X?'J)A_P`H]0ZYR82S1PKJN#VF35KJ+\#] MPRCFB[U^[:,&2!%%GCI\LBU;)(E`3J*+KN#D1(F`=1,)C``!]N?61D^XKA+S:>9+R@>C[ZAUYL^='@%PQB)J,=[7B=W;:9)+)L-1:2E&%KECR92 MB9%O9+/'KJ5>H,A4``5.ZZH'*:5 MH-IT[AVJKYKK;"8-IADD$EY30#77=4]_>J0&^-Q^0GSZ\I8\*IJV;NK:&,>- MU[K"GE=$U'I*OR+D@.).T6R0,E`LY%VF4#RDR]6*[<>V5-%`"$31#T9BL/T? M]*\"ZXO^22X<*5/+4FFP#CV#8M*W;\YU]D7?+N-'DEH2-M])E>:7):OZ^"R;;DXAPI2ZO\`NZV?2]KQ6J*OVM_Q=I5)*4IP M(/9,2>^X=+@X%($D4T1TA>?5+YOK&TR_DQCINU#F\@I4AS9&\QTH:&2H!)]: MV'#T"8NDI<892Q8^\S.ZO+]RCXS;"TW&<`X[B3Q@<. M&+K=FW=L\I^-GS=@J<'86CN+BWD_)["JE0UU3YB:;L5'AW+ARZ==I&WN(D45 M(K*=#6'16)RL5\_)&]RP!\J..WG\+BT@D`,H!TU+@&@FE?4H0/#[KKR(<4N8;/;W$S5>@N4UE9Z_L<#LW2VO^ M:/$>V2]DU/,RE>_%GB@T3==HF:T,/9FD4LVDU&2[5)X":*I#E7[1OW6UUTSF M,(;+,S7-I$9&F.5]K.)H=5I<"VH)%2-BKN"BREE?B>R9%,\-(*-KXAV^-LRT*PU_;=F:\VFZG85 M*+BWJ=K8V#7+QU%MX]=^]7:%;N`2=`=H8XD`AR"/FS,6./L+EL6-O&7L!94O M:Q\=#4CE+7BM:`&HTU6T+*XN;B(ONH'02!U.4N:ZHH-:MT[/0H@/)KR7\P%H MI/(30G$SQTKUBEOVE\H:O+*ZF MWZ).S#^K:AK?-OAO<)?8$*[IM@B+E`Q\/4-]R]D.=2C2$@J#MHV<'8@E\R8A MTTCE'=W5&0P.2P5S999]W;V4C0'2.M;EH80X%I)="&_&`*$BNRM2J'BK;(6M M_%/9B&2=I-&B6(EPH010/)V5U&S:NPKXK\K.9.YK\E4.0/C;V1Q1K85>3EW. MS+!OW1^T:Q^/L5HU)I5VL31)<#D$,L;J&OBJ\W]Q)R75H^!M*\Q>QPKP\.JUE\ MUO%;@1RYTC6-<*NV62EAG>-NWMH;(U_0IJ)G&R$>C96#.,NUEK1[S M1)(JK).=CD%0[.K9"->4U:UW( M\:\CCVBA!*P^H++&WUN(KZ6.&?4QNS&*KGH7063B.9E[$Z$-=P#I`UG-PY:T9:9*RNZ8YXD MG&QT#P\D=S274['-HIZM)\O?JO-R*,-&W!+6_'[DCK7='D^YQT/E=Y.[N MS=HZ2JNS=EU:(B=9H.2+FDHOB_IJ>?PDC,3'LE4!>9CX5JUQT`G[#'16UTR?,7#9LNX> M`.[.X_Q M>PM@4VCV#:*$4U9Q^V];45O:YR'7L\G*5"21>E9,2KKJ2+!@3M`5"==H?2B_ MO[+J(L@BFEQ\[1',6,<\1UJ8WOY0>4!P(J:#E+N"JG5]O;SXWFD>QERP\S.9 MP!=^4T5(KIK0;P%J%])OI?2U,T_O/;I]DZGL/);;4PU8/-9U_8%)L>SM::*H M4@M%0S^U5*$G']DJK.^7IZ\="9ZV0(X;-HXP"/4N37UCOK^>]M[+RIFXJ%M1 M(6/;&^5XJ0UQ`:XL8`-":$N6#T5;V\<$D_.PW;S\(<"YK&Z"H!J*NKM[%;\S M2JO*B#\Z&FM+;W\;^[*%M_9>K=2RI4F5JT?<-M7JJZ\@!WO36TC9J/6(ZP6^ M6AHL9B[,HV0A_8*J*IV;YP8"B!#"%U^GU]?X[JB"XLHIIF:ME;&QSSY+J->X MAH)HPD.K2E0%!=1P6]SBI(IWL8[:PN(:.<:@5)&IU'<2J_/TE&F]/1]HY";W MM&Q=6*\@)Z'2UEK+4!-@TB2VQ#:MA5H*Q[,V&K064R[M+&NSUFD82-3D!;D0 MZQRA.\2K!W;(^LM]>NBML=#%-_#6N\R23D>(S(:MC9SD!I<&A[N6M?$."K/1 M%O`'RW+WL^9(Y6MYAS!HH7.Y:UH305[.U7@LT$MAK6CFA$P\]P\Y6P=AD(R) M@YGC?N^*EI2:>M(V(C8^1UG9FCI_)R+]5!DP8LT5A4565.1-(A1,8P``CDK@ MGOCS=G)&"Z1MU$0`"22)&F@`U)/`+$R`:ZPG:\@-,+ZUV?"=JJJ^#SF7Y%^) MW#K4E?W?P2Y%\E.%UDC7,WQ\V]QSCJSMG:-%K+Z0>'=UN4U="6=6TS]!+,@X M6BU12:OH],YT2D<-_ER(;?Z^P?3&9S0[F/R9T M7L+CKP4\??,>A3>TZ;8*KL#DGR]U(\XIZHTYKN7BG+2\6%&7VRZB@7DD*RJZ M*+Y?Y9&+()G1"N5$B)#7NG.FL'BLA%D^H,E8R1PO#F06T@N))7@^!M(ZZ:4VZK)O@7XF<5.&7&C8 ML#H7DCQ_YA/NV:'L")C'R$5,(ZXUM"K5^2 M9&IY1\L\=&(F3H@WQ/J)F:@5<=.8-KR@- M&NT]O35E96%HYMM+%/=&A>6.:X;#RM%#H-M":5-3W<\YRV#EIN>FPT/:-)PV MC]51D\QDGCBX[=U=97[XG-[90#&P M$>&L9W/AG=<7A:0.6.31N^@#2>\[AWKMR+KVXC#7QB.$'>YNIW:U`]"QAP4) MR6TO9[I):VUG4-UUF;90K2[0-1W/JA^]BW#1625@)).2A;9.)1SDY%G:94W* M/8Y)W=HE%/KF7U`<5?PQMNI9()FDEA=%(`:TJ*%HKNV;/2NG&_-V[W&)C9&$ M"H#V^C83VJ8_6NV=Q7"SH0MUXTVS5T(HP>.5K7+7V@6%@@[;E3%O'_A]>DW$ MHHH^,<0*<$^PG;][IU#*1=6=C!$9(+IDTE1X0Q[33C5PIHIV&>XD?RR0N8VF MTN:?=JMBLC%EJ%_GIQTT1LBUS=VHN[]*4/=3(4VMXHMLV13ZXWM#ILU2^77? M)O)9)U6[<5G[1!.ND"#M+L%7VS![QKUT[D\C:PM@N+>>2P/P/:QSN7NH/$VO M#4;J[%`9*UMI7F2*2-MP-K2X"OX#[UH%H^6YIZH/(J:$:;"FH).16;R;?7T4 MAN+7+B3((`N)S5I*W5,'QB].Y5!5)<2_$V6._9@KP`9$Q-DIISGRWT_.Y74[ M#HHRW=D(*_+!Q;77E\;?94*0*CNO*9OCLB)J5:Z(JJ_:C*VR5I\16+"1N/7W M31,.H1[:3OS$Z]@D*P3`W3JN3XY6[@=(X[QQ@W$PV-#BYOI.C:>ON4G&.9+=QNBMJ4C;REK`W^KH`>TC; MZ@I*TBMX&N9"X/E_&-07$]O#N6M?(/;'-2[:YMM3I?%M?7$?-0HTM9 M6J]0,BL_A:U$;ITW.N)YH2.=IS,6,7#;!6DW+)W!*."K&1#O22ZJ`(=G4+ED M;K'SV4D-[YK+=PH7&*44U%#4LI4&E*]RA+6*YCG:^#D=(#H`]AKQ%`[@K%>G MMG[BO$DYC=F\>9S4"36&!Z6<>7JGVR*D90KIJW-$LD()R,HD8Z*RBY5%D2D` MB0E$>X0ZZSO;2QMVAUI&BUTYW MZ7T#N2)B6-XVSK;4.WX:-7=T>=N-KKT"L_B%7"@+14S&R((!`=3<=HV[B,7)6]M.T"1[ M(YP-"2!IP-=WN4)%$JG)74]^D?W$R[^RV6-1(9_)PNY=?LE5Z-EW#*? MEB2\?D$.]=*^T*0&D;-\L&RCHU]A6%*<50`2=6^\:VAJ,5FD?H0[I7]H613K M*)@/=T:1JRG7X%RN3VG1UJ/-<_G/Y+'E]?5]]P4G'+FIO"!R]I:![_O!;L:` MTAK_`%3L7\3VON6(W%RTL4,HHL_M-FC5+-#P/LBH\C]?4QX_-*Q-?*CU]YRD MW*95(.G1%(12R`R-_PG;Q.JD+:WBAEK/()+ MTC>=0/ZHV@+X'D36EZYS8Y)('-H_D:7%NNCJ`'8?83 M35<8@`\1JHS>'>YN5NAX^;A]?Z5LFZ]9R$^Z,[8UN-E;-! MQEG12;(22U?OM(;66O(K+H$1^:1,=PB;H0X>V8QC'M6;L-#H=VJB+&XO;8%L49DA)W5(KV.%0I(?V4WKR"BG%JY72\9QVT$ MP;&>R&H*_:"QEYY-[6C'5I?Z3NL;&:YJQF5>U=4$5&:$I[KKW3@K:K=>JP+!UKG8&MHUC>YU M"JNFQ7$-&6&LQ$FO+'9MF:A"M'``58K;L3.D82@8QW@FNHI(8Z48UP(\-=NH%23M([MRRL=#!!!R M0O:]U?$00=?1[%S/E?0M&;+U>M4-Z6^KT*,D7P&J5NL-A@JT[@[8@U<*-'D$ M]GG;-JZ>%:@J"[7N,#EJ*A#``?>+T8>XR%K=^?CV/D>!XFM:7`MX$`'3@=QH MN=[%;30\ERX-!.A)`H>RONX*NC,:8V9JG9,:CIW8M4V9/I/%E*=9N/\`L:!L M=I>%3+W&,C5ZW-N;DQPU![`JLZWF@E'D/:]^XL<"?4#5;P4C=7E:EBM:U'4.V.7!P3;)3E\U$ MQK!T`#H4%WDU865;B3]H>ICJ$4,/QZ".0%Q8='LK*^1E.#)"[U!I<5(1W&:= M1@:[O6,D"0UROO1 MA6%HM::QRE3%NS*1)3H)2K'[%2PMQD>>!]IT];OCM*?K'M:2]P_K.%2UO>?5 MJ%G16W+(V;)2-=-7PM)``/8-*GT*3+*JI=,(F$3")A$PB81,(F$3")A$PB81 M,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(ORO`;BU<_."@#/V%OFQ M=>T+;Y;VS>_\R"WZGV/:Z]_?]WMZ]?3/@#B\S8JF@?!))'7<0:;:5IXN*IV2QO1M][2Q(=0ZKU.RQ;KVA-ZBNO$[):@(@7_K`'7[> MF9T?7O1S#4=-VA=]IG_X2L1W2753@0[-2AOV9!_]Y:@[7\&46Y1.[YU^>"T. MX/\`^9M;]>82LQIR@?J?JKM#=DC$(@;X?>9F`H^OK\,L.,^H[V#_`.,],M$E M?]4TOU[F0[?:H>\Z,!/_`!K-@G=SGETW_%,2=5SS0?B_^FPTPY93-VYK\:>0 M\LS.0XCMSG#I%&JBY2,4Q5%:A2KI5HQYU,'WDW9W*1P'H8HAF-F>J_K%DH7< MUCD;6WIL9:S@4[RVE%E8SISZ=6CJW-[:3SC\J:*I'=SE6=.-#7B^SUG&M>(J MFBSZ@;B5&+'CVYHSVAF63(!1,D^H*[B'=.S)@'>IVST+8^,&(9;!F($/RHWQEKAZV[5L-]G_`$_G_+D
-----END PRIVACY-ENHANCED MESSAGE-----